NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Investor protection law firm Kaskela Law is investigating the Global Business Travel Group, Inc. (NYSE: GBTG) (“GBTG”) shareholder buyout to determine whether the transaction as structured is fair and provides investors with a sufficient price for their GBTG shares.
Click here for additional information: https://kaskelalaw.com/case/global-business-travel-group/
On May 4, 2026, GBTG announced that it had agreed to be privatized at a price of $9.50 per share in cash. Upon completion of the transaction, GBTG’s public shareholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.
The investigation seeks to determine whether GBTG shareholders are receiving sufficient monetary consideration for their shares, and whether the company’s officers and/or directors breached their fiduciary duties or violated the securities laws in agreeing to the $9.50 per share buyout price. Critically, at the time the buyout was disclosed to public investors, at least one stock analyst was maintaining a price target for GBTG’s shares of $12.00 per share – over 25% higher than the buyout price.
GBTG shareholders are encouraged to contact co-lead investigative attorney Adrienne Bell, Esquire to discuss their no-cost legal rights and options at (484) 229 – 0750, by email at [email protected], or by filling out the firm’s online form at:
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis (i.e., the firm’s clients are never responsible for any out-of-pocket costs for legal representation). Since 2020, the firm has aided in the recovery of over $500 million for investors. For additional information about Kaskela Law LLC, including the firm’s recent notable recoveries for investors, please visit www.kaskelalaw.com.
CONTACT:
This notice may constitute attorney advertising in certain jurisdictions.
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- Old Republic International Corporation (NYSE: ORI) – today announced that it will report financial results for the second quarter of 2026 before the market opens on Thursday, July 23, 2026, and will hold a conference call at 3:00 p.m. Eastern time to discuss results. The call can be accessed live on Old Republic's website at www.oldrepublic.com or by dialing 800-715-9871, passcode 2246765.
Investors may also access a replay of the call by dialing 800-770-2030, passcode 2246765, which will be available through Thursday, July 30, 2026. The replay will also be available on Old Republic's website.
About Old Republic
Old Republic is a leading specialty insurer that operates diverse property & casualty and title insurance companies. Founded in 1923 and a member of the Fortune 500®, we are a leader in underwriting and risk management services for business partners across the United States and Canada. Our specialized operating companies offer significant expertise in their fields, enabling us to provide tailored solutions that set us apart. For more information, please visit www.oldrepublic.com.
At Old Republic:
At Financial Relations Board:
Craig R. Smiddy: President and Chief Executive Officer
Enterprise Products Partners is positioned to benefit from AI-driven energy demand and global energy market disruptions, supporting resilient, long-term growth. EPD just raised its dividend for the second time in a year, offering a 6% yield with the potential for accelerated future dividend growth as capex declines. Forecasted EBITDA growth averages 6% annually through 2028, with lower leverage and increased free cash flow enabling higher shareholder returns via dividends and buybacks.
ATLANTA--(BUSINESS WIRE)--Asbury Automotive Group, Inc. (NYSE: ABG), one of the largest automotive retail and service companies in the U.S, is proud to be recognized on TIME's list of America's Best Companies 2026. This prestigious award is presented in collaboration with Statista, one of the world's leading statistics portal and industry ranking provider. “We are honored to be recognized by TIME,” said Dan Clara, Asbury's President and Chief Executive Officer. “This recognition is a testament.
NEW YORK--(BUSINESS WIRE)--CRH (NYSE: CRH), the leading provider of building materials, will publish its Q2 2026 financial results before market open on Thursday, July 30, 2026, in advance of a conference call and webcast presentation at 8:00 a.m. (EDT).CRH's results and the related presentation will be available at www.crh.com/investors/results-presentations.Registrations for the event can be made at www.crh.com/investors. Upon registration a link to join the call and dial-in details will be ma.
Brisbane, Queensland, Australia--(Newsfile Corp. - July 9, 2026) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce positive performance test results for its THERMAL XR® ENHANCE coating - now surpassing 30,000 hours of salt spray testing under test method ASTM B117-19 at an external laboratory.
Figure 1 shows the certification of no corrosion after 30,000 hours of salt spray testing from an external laboratory in the USA.
Figure 1: Certification of 30,000 hours of salt spray test ASTM B117-19 for THERMAL-XR®
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8082/304571_b07b8c7464006bc2_001full.jpg
Figure 2 shows the images of the THERMAL-XR® coated plates upon the commencement of tests. Figure 3 shows the images of the various THERMAL-XR® coated plates after 30,000 hours of salt spray testing.
Figure 2: Image of THERMAL-XR® coated plates upon commencement of tests
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8082/304571_b07b8c7464006bc2_002full.jpg
Figure 3: Images of THERMAL-XR® coated plates after 30,000 hours of salt sea spray testing
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8082/304571_gmg3en.jpg
GMG's Managing Director and CEO, Craig Nicol, commented: "Reaching more than 30,000 hours of ASTM B117-19 salt sea spray testing with no observed corrosion is a significant validation of THERMAL-XR® ENHANCE in one of the harshest standard corrosion test environments available. To put this in context, many premium automotive, building and industrial coatings are benchmarked at around 1,000 hours, and high-performance marine and offshore systems at 2,000 hours or more, with extended programmes for some advanced systems reaching into the low thousands of hours. By surpassing 30,000 hours in continuous salt spray testing while also delivering improved heat transfer under high air-flow conditions, THERMAL-XR® ENHANCE demonstrates truly next-generation performance in both corrosion protection and heat-exchange efficiency."
GMG's Chairman and Non-Executive Director, Jack Perkowski, commented: "It is fantastic to see THERMAL-XR® ENHANCE providing measurable benefits in such an important application - space cooling, refrigeration and data centres in demanding operating and environmental conditions. These results, combined with our growing regulatory approvals and distribution footprint, give us confidence in the role THERMAL-XR® can play as a global benchmark coating for energy savings and corrosion protection."
THERMAL-XR® ENHANCE Development and EPA Approval History
MonthSignificant Milestones for THERMAL-XR® powered by GMG GrapheneSeptember 2022GMG acquires THERMAL-XR® manufacturing intellectual property and brand rights
GMG ACQUIRES THERMAL-XR MANUFACTURING INTELLECTUAL PROPERTY AND BRAND RIGHTS AND GRANTS RSUs TO DIRECTORS AND OFFICERS - Graphene Manufacturing Group | GMG (graphenemg.com)December 2022Verified Improved Heat Transfer by The University of Queensland.
VERIFIED IMPROVED HEAT TRANSFER ON ALUMINIUM WITH THERMAL-XR® & MARKET UPDATE - Graphene Manufacturing Group | GMG (graphenemg.com)February 2023Approval from Australian Industrial Chemicals Introduction Scheme (AICIS)
GMG RECEIVES REGULATORY APPROVAL TO ENABLE SIGNIFICANT COMMERCIAL SALES - Graphene Manufacturing Group | GMG (graphenemg.com)April 2023Total available market for THERMAL-XR® estimated by Company to be > US$28.4 billion
GMG ANNOUNCES COMMERCIALISATION PROGRESS OF THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)April 2023First order of THERMAL-XR® > $120,000
GMG ANNOUNCES COMMERCIALISATION PROGRESS OF THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)May 2023Signing of Distributors for Singapore, Thailand, Indonesia & South Korea
GMG SIGNS THERMAL-XR® DISTRIBUTOR AGREEMENTS IN 4 ASIAN COUNTRIES - Graphene Manufacturing Group | GMG (graphenemg.com)June 2023Independently Verified Heat Transfer & Energy Savings
GMG ANNOUNCES INDEPENDENTLY VERIFIED HEAT TRANSFER AND ENERGY SAVINGS RESULTS FROM THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)July 2023Signing of Nu-Calgon Distribution for North America - USA, Canada, Mexico, & Caribbean.
GMG APPOINTS NU-CALGON AS THERMAL-XR® DISTRIBUTOR FOR NORTH AMERICA - Graphene Manufacturing Group | GMG (graphenemg.com)August 2023Commissioning of THERMAL-XR® Coating Bulk Blend Plant
GMG PROVIDES COMMERCIALISATION PROGRESS OF THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)October 2023Forward Orders > AU$ 400k - Conditional on Import Approvals for some Countries
GMG PROVIDES COMMERCIALISATION UPDATE ON ENERGY SAVINGS COATING THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)December 2023Commissioning of the modular Graphene Production plant
Graphene Manufacturing Group Commissions Modular Graphene Production Plant - Graphene Manufacturing Group | GMG (graphenemg.com)January 2024Canada Approval Department of Environment and Climate Change Canada (ECCC)January 2024Launch of Nu-Calgon CoolWorx® powered by GMG Graphene at Chicago AHR Expo 2024.
Launch of Nu-Calgon CoolWorx® powered by GMG Graphene at Chicago AHR Expo 2024.April 2024GMG Provides Commercialisation Update on Energy Savings Coating THERMAL-XR®
GMG Provides Commercialisation Update on Energy Savings Coating THERMAL-XR®December 2024GMG Reaches Market Commercialisation Milestone on Energy Savings Coating THERMAL-XR®
GMG Reaches Market Commercialisation Milestone on Energy Savings Coating THERMAL-XR®December 2025USA EPA Approval Conditions Accepted for Graphene Coating THERMAL-XR®
USA EPA Approval Conditions Accepted for Graphene Coating THERMAL-XR®December 2025USA EPA Approval Conditions Accepted for Graphene Coating THERMAL-XR®
USA EPA Approval Conditions Accepted for Graphene Coating THERMAL-XR®March 2026THERMAL-XR® Sales in the United States to Commence after GMG Receives US EPA Approval
THERMAL-XR® Sales in the United States to Commence after GMG Receives US EPA ApprovalJune 2026GMG Delivers its first ever bulk shipment of THERMAL-XR® to Nu Calgon in the USA
GMG Delivers its first ever bulk shipment of THERMAL-XR® to Nu Calgon in the USAAbout THERMAL-XR® ENHANCE powered by GMG Graphene:
THERMAL-XR® ENHANCE coating system is a unique method of improving the conductivity of corroded heat exchange surfaces and improving and maintaining the performance of new units at peak levels. The process coats and protects heat exchange surfaces while improving and rebuilding the lost corroded thermal conductivity and increasing the heat transfer rate by leveraging the physics of GMG Graphene, resulting in an efficiency improvement and a potential power reduction.
THERMAL-XR® ENHANCE is now patented for 20 years in Australia and is expected to be patented in other countries around the world.
About GMG:
GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.
The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.
In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium-ion batteries.
GMG's 4 critical business objectives are:
Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation Battery Develop Supply Chain, Partners & Project Execution CapabilityNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.
This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects", "anticipates", "plans", "estimates" or "believes", or variations of such words and phrases, or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. These statements, referred to herein as "forward-looking statements", are not historical facts and are made as of the date of this news release.
Forward-looking statements in this news release include, without limitation, statements regarding: the Company's expectations relating to the performance, durability, energy savings and enhanced corrosion resistance of the THERMAL-XR® ENHANCE graphene coating product in commercial applications; the Company's belief that THERMAL-XR® ENHANCE represents next-generation heat transfer technology and a global benchmark coating; the anticipated benefits of THERMAL-XR® ENHANCE in radiators, HVAC-R systems, engine cooling and other industrial and building applications; the Company's expectations regarding market demand and commercialisation of THERMAL-XR® ENHANCE and related products (including Nu-Calgon CoolWorx® powered by GMG Graphene); references to typical ASTM B117-19 salt spray benchmark durations for premium automotive, building, industrial, marine and offshore coatings and statements comparing those benchmarks to THERMAL-XR® ENHANCE's extended salt spray test duration; and the Company's regulatory and commercialisation plans in the United States and other jurisdictions, including the implications of approvals or consent orders from regulators such as the United States Environmental Protection Agency (EPA) and the Department of Environment and Climate Change Canada (ECCC), GMG's intentions to develop commercial scale-up capabilities, GMG's focus in the energy savings segment, GMG's intentions for the use of graphene lubricant additive on saving liquid fuels, expectations for R&D and commercialisation of G+AI Batteries, GMG's ability to improve the performance of lithium-ion batteries and the Company's four critical business objectives.
Such forward-looking statements are based on a number of assumptions of management, including, without limitation: that the results observed in laboratory salt sea spray testing and other technical evaluations of THERMAL-XR® ENHANCE (including extended ASTM B117-19 test durations) will be indicative of performance in real-world commercial operating conditions; that THERMAL-XR® ENHANCE will continue to perform as expected over extended periods; that comparisons to typical salt spray benchmark durations for other coatings are a useful indicator of relative corrosion-resistance performance, recognising that ASTM B117-19 is an accelerated, comparative test method and not a direct predictor of in-service lifespan; that regulatory approvals, consent notices and other permissions (including those from the EPA, ECCC and other national or regional authorities) will remain in effect on terms acceptable to the Company; that the Company and its distributors will be able to market, sell and deliver THERMAL-XR® ENHANCE and related products into target markets as planned; that sufficient customer demand will develop for energy-saving and corrosion-protection coatings at the performance levels contemplated; and that the Company's cash position, access to capital and business fundamentals will remain supportive of its commercialisation plans.
Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: the risk that laboratory test results, including salt sea spray testing duration and performance, do not translate into equivalent real-world performance; the risk that extended salt spray test durations may be misinterpreted as direct indicators of product life in service; technical de-risking and market acceptance risks for THERMAL-XR® ENHANCE and other products; construction, scale-up, manufacturing and supply chain risks; the risk that required approvals, consent notices or permits are not received, are delayed, are revoked or are received or maintained on terms that are not acceptable to the Company (including from the EPA, ECCC and other regulators); changes in environmental, chemical or product-safety regulations; competitive product and technology developments; overall economic conditions and capital market volatility; foreign exchange fluctuations; and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated November 4, 2025 available for review on the Company's profile at www.sedarplus.ca.
Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that is incorporated by reference herein, except as required by applicable securities laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304571
Source: Graphene Manufacturing Group Ltd.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
PAWTUCKET, R.I.--(BUSINESS WIRE)--Blooms by Play-Doh invites adults to slow down, create and display realistic floral arrangements using Play-Doh compound.
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)---- $VENU #CBRE--Venu Holding Corporation ("VENU" or the "Company") (NYSE AMERICAN: VENU), owner, operator, and developer of premium live entertainment destinations, today announced that CBRE Group Inc. (NYSE: CBRE), retained by the Company to secure Commercial Property Assessed Clean Energy ("C-PACE") financing, has identified more than $150 million in gross proceeds for VENU®. C-PACE proceeds are expected to fully fund the balance of construction for Regent Bank Amphi.
World's tallest, fastest and longest giga dive coaster makes history
Tormenta Video and Photos: Click Here
, /PRNewswire/ -- The wait is finally over as Six Flags Over Texas today unleashes Tormenta: Rampaging Run. Breaking six world records, Tormenta: Rampaging Run is the tallest, fastest, longest and first-ever giga (any coaster 300-399 feet tall) dive coaster in the world. Themed after the exhilarating power and strength of the legendary bull, the park's newest signature attraction towers over a new Spanish village called Rancho de la Tormenta, located in the park's Spain area.
Daring villagers are carried 309 feet above the ground, giving them a breathtaking and panoramic view of Arlington, the Dallas-Fort Worth Metroplex and Six Flags Over Texas far below. Just before the terrifying 285-foot first drop, the train pauses over the edge for three seconds, giving riders a new sense of fear as they stare straight down at the world below. After what feels like an eternity, Tormenta begins its Rampaging Run, speeding through a tall and twisted layout.
Tormenta: Rampaging Run's World Records
Tallest dive coaster – At a height of 309 feet, Tormenta: Rampaging Run towers over every other dive coaster in the world. Fastest dive coaster – Reaching a top speed of 87 mph, no other dive coaster is faster. Longest dive coaster – The legendary bull runs fast through 4,199 feet of weightless "airtime" moments, sharp turns and drops. Tallest vertical loop – Rising 179 feet, the vertical loop is the highest on any roller coaster in the world. Highest Immelmann inversion – Riders are flipped head over heels at 218 feet in the ride's first upside-down moment, the Immelmann – a fighter jet-like maneuver that takes the train into a half loop, then a half roll before traveling in the opposite direction. Highest beyond-vertical drop – Once the train is finally released from its hold, it drops riders into a 95-degree, beyond-vertical drop as they plunge 285 feet toward the earth. "Tormenta: Rampaging Run forever changes not only the Arlington skyline, but the full lineup of thrills only offered at Six Flags Over Texas," said Pete Carmichael, park president of Six Flags Over Texas. "With the addition of this record-breaking dive coaster, Six Flags Over Texas is a must-visit destination for thrill lovers from all over the world, and we can't wait for our guests to take their first rampaging run!"
Rancho de la Tormenta Plaza
This new and immersive themed area depicts an old and secluded Spanish village, warmly inviting guests to partake in the excitement of the annual festival celebrating the ranch hands who raised the cattle that brought prosperity to the community. The "Festival Taurino" offers an atmosphere filled with vibrant and colorful banners, a range of entertainment and its signature attraction, Tormenta: Rampaging Run.
The town was initially named after the storms (tormentas) that swept across the plains it occupied, but that soon changed with the birth of the legendary bull that grew to be the most feared and respected animal in the land. Known for its fierce strength and incredible speed, the bull, nicknamed "Tormenta," came to be a symbol of the town's resilience and might.
Six Flags Over Texas 65th Anniversary
In 2026, Six Flags Over Texas celebrates 65 years of family fun. Opened on Aug. 1, 1961, the park marked a new era in family entertainment and set a precedent for future amusement parks. As the original park in the Six Flags family, it's celebrating with special events, giveaways and many surprises throughout the summer that honor its legacy and past.
Tormenta: Rampaging Run opens to the public today. Guests looking to ride Tormenta: Rampaging Run all season will find the best value in a 2026 Gold Pass, providing season-long access to Six Flags Over Texas, Hurricane Harbor Water Park, free general parking, bring-a-friend discounts and more.
About Six Flags Over Texas
Six Flags Over Texas is home to more than 100 rides, shows and attractions, including 14 world-class roller coasters like New Texas Giant and Titan. Six Flags Hurricane Harbor, the largest water park in North Texas, features more than 40 rides and attractions, including Typhoon Twister and Tsunami Surge. Six Flags Over Texas and Hurricane Harbor are the premier destinations for thrilling family fun.
About Six Flags Entertainment Corporation
Six Flags Entertainment Corporation (NYSE: FUN) is North America's largest regional amusement-resort enterprise. The Company operates a premier portfolio of 20 amusement parks, 14 water parks, and nine resort properties across 13 U.S. states, Canada, and Mexico, as well as an amusement park in Saudi Arabia. Focused on its purpose of creating FUN, thrills, and a lifetime of memories, Six Flags provides immersive entertainment to millions of guests every year with world-class coasters, themed rides, and thrilling water parks powered by beloved intellectual property such as Looney Tunes®, DC Comics®, and PEANUTS®.
Creates Unified Operations Organization Spanning Factory Floor to Customer Delivery as Enovix Scales High-Volume Production July 09, 2026 07:30 ET | Source: Enovix Corporation
FREMONT, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Enovix”), a developer and manufacturer of advanced lithium-ion batteries, including proprietary silicon-anode architectures, today announced that Dr. Michael Vyvoda, former Director of Product Operations at Apple who helped scale AirPods manufacturing to high-volume production, will join the Company as Chief Operating Officer, effective July 29, 2026. Michael will report to Dr. Raj Talluri, President and CEO, and will assume responsibility for Enovix’s global manufacturing, supply chain and operations engineering organizations as the Company scales to sustained, high-volume production at its Malaysia and Korea manufacturing facilities, with R&D support from its India operations. Senior Vice President Kihong (“KH”) Park, who leads Global Manufacturing Operations; Ed Casey, who leads Advanced Manufacturing Engineering (AME); and James Wilcox, Vice President of Strategic Sourcing, will report to Michael, establishing a unified operations organization with end-to-end responsibility from the factory floor to customer delivery.
Michael’s appointment comes as Enovix accelerates the commercial execution of its next-generation battery platforms. As reported in its first quarter 2026 results, Enovix grew revenue 49% year over year to $7.6 million, exceeding the high end of guidance, delivered its sixth consecutive quarter of positive gross profit and expanded its global pipeline for Korea-manufactured products to more than $130 million. Production of Enovix’s silicon-anode battery for smart eyewear is underway following receipt of its first commercial production order of approximately 50,000 units, smartphone qualification continues to advance and the Company recently launched its MX-1™ platform for the rapidly growing drone and defense markets. As these programs scale simultaneously, successfully coordinating manufacturing, supply chain, quality and customer delivery across multiple sites, products and end markets becomes increasingly critical. In his new role, Michael will lead this next phase of operational execution, driving a disciplined, repeatable manufacturing ramp across Enovix’s global operations.
“Michael brings exactly the kind of broad, cross-functional operating leadership Enovix needs at this stage,” said Dr. Talluri. “We are scaling into sustained, multi-site, high-volume manufacturing across smartphone, smart eyewear, defense and industrial platforms simultaneously. Michael has done this before — building manufacturing organizations that successfully transition products from introduction to high-volume production while improving yield, throughput, cost and operational discipline. Just as importantly, he understands how operational excellence translates into customer success, commercial execution and long-term shareholder value. With Michael, KH, Ed and James, Enovix now has a deeply experienced, fully integrated operations leadership team. Michael’s arrival further strengthens my confidence in our ability to execute our manufacturing ramp across these programs.”
Dr. Vyvoda brings more than 25 years of operations and manufacturing leadership experience spanning high-growth startups and global technology leaders. He joins Enovix from Magrathea Metals, where he served as Chief Operating Officer, leading operations for the company’s electrolytic magnesium development platform. Previously, he was Chief Operating Officer at Aircapture, where he took direct air capture technology from early development through commercialization, achieving successive generations of capital cost reduction. Earlier, Michael spent more than five years at Apple as Director, Product Operations for Audio Products, where he helped scale AirPods manufacturing from new product introduction to high-volume production across multiple Asian manufacturing sites, while leading cost reduction initiatives to support margin expansion. His operations background also includes senior manufacturing roles at ThinFilm Electronics, GT Advanced Technologies, Twin Creeks Technologies, SanDisk and Matrix Semiconductor. Michael holds a Ph.D. in Chemical Engineering from the University of California, Berkeley and a B.S. in Chemical Engineering from the University of Michigan.
“Enovix is at an inflection point — scaling from technology leadership into sustained, high-volume commercial manufacturing,” said Dr. Michael Vyvoda. “Scaling manufacturing at these levels requires repeatable processes, disciplined execution, operational visibility, continuous improvement and relentless cost reduction — all while upholding the highest standards of quality and safety. What drew me to Enovix is the rare combination of genuinely differentiated technology and customer demand across multiple large end markets. I’m looking forward to working with KH, Ed, James and the broader operations and engineering teams to scale a world-class manufacturing system supporting multiple high-volume product platforms for Enovix’s smartphone, smart eyewear, defense and industrial customers.”
Dr. Vyvoda’s appointment completes the deliberate strengthening of Enovix’s operating leadership as the Company advances from technology development to commercial-scale manufacturing, following the earlier additions of Ed Casey as Vice President, Operations, leading Advanced Manufacturing Engineering, and Sanghyuck Park as Senior Director, Advanced Manufacturing Engineering.
About Enovix
Enovix develops and manufactures advanced lithium-ion batteries, including proprietary silicon-anode architectures for smartphones, smart eyewear, defense, industrial and emerging edge-AI applications. Its proprietary silicon-anode battery architecture enables higher energy density and performance in space-constrained devices while maintaining safety and reliability, supporting commercialization across consumer and industrial markets.
Enovix is headquartered in Silicon Valley with manufacturing facilities in Korea and Malaysia and R&D operations in India, servicing customers globally. For more information visit https://enovix.com and follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or our future financial or operating performance and are identified by words such as anticipate, believe, could, estimate, expect, intend, may, might, plan, possible, potential, predict, project, should, will, would and similar expressions. Forward-looking statements in this press release include, but are not limited to, statements regarding: the expected timing, benefits and impact of our leadership appointment and organizational changes; our future growth opportunities; our ability to scale multiple programs simultaneously, and execute on our manufacturing ramp; among others. These statements are based on the current expectations of our management, are not predictions of actual performance, and actual results may differ materially from the future results, performance or achievements expressed or implied by the forward-looking statements.
Risks, uncertainties and assumptions that could cause actual results to differ materially from the results and events anticipated by such forward-looking statements include, but are not limited to: risks related to the timing of the leadership changes; the outcome of customer testing and qualification activities, including the possibility that our products do not meet required performance thresholds or that such testing is delayed beyond expected time frames; our ability to successfully develop, manufacture and commercialize our battery products and transition to high-volume production; our ability to scale manufacturing operations and achieve expected production capacity and yields; the level and timing of customer demand, qualification and adoption of our products across end markets; our ability to enter into and expand commercial agreements, including securing design wins, purchase orders and production contracts; our ability to execute on our business strategy and build and scale our sales and commercial capabilities; lengthy and unpredictable customer qualification and sales cycles, safety considerations and contractual terms, particularly in defense and other regulated markets; risks related to battery performance, reliability and safety; customer concentration in the defense sector and certain consumer technology markets, such as smartphones and smart eyewear; challenges in forecasting demand, inventory and manufacturing requirements that may result in additional costs and production delays; our history of losses and expectation of continued losses; risks associated with the development and commercialization of products that remain under development and may not be successfully produced at commercial scale; our ability to effectively integrate and derive benefits from acquired businesses; fluctuations in foreign currency exchange rates and interest rates; operational and safety risks associated with manufacturing equipment; intense competition and our ability to keep up with rapid technological change and evolving standards in the battery industry; our ability to attract and retain qualified personnel; the outcome of litigation, regulatory investigations and other legal matters, including the associated legal and other costs; liquidity constraints, capital availability and our ability to service existing debt; our ability to protect and enforce our intellectual property rights; volatility in the trading price of our common stock; changes in tax laws or regulations; the impact of cyber and other information technology or security related incidents on us, our customers or other parties; changes in the political, economic or regulatory environment generally and in the markets in which we operate; and other risks described in the disclosures contained in our filings with the Securities and Exchange Commission (“SEC”), including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of our annual report on Form 10-K and quarterly reports on Form 10-Q, and other documents that we have filed, or will file, with the SEC. These documents are available in the SEC Filings section of the Investor Relations page at https://ir.enovix.com and at www.sec.gov.
It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Accordingly, you should not rely on any of the forward-looking statements. Any forward-looking statements in this press release speak only as of the date on which they are made. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
For media and investor inquiries, please contact:
Investor Contact:
Blueshirt Group
Monica Gould / Amy Grant [email protected]
First peer-reviewed publication of chemotherapy-resistant gamma-delta T cells (DeltEx Drug Resistant Immunotherapy or DRI) clinical results in newly diagnosed glioblastoma
Repeat-dose patients achieved median progression-free survival (mPFS) of 16.1 months, more than double the ~6.9-month standard of care benchmark, with no dose-limiting toxicities (DLTs) NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for cancer and autoimmune diseases, today announced the publication of peer-reviewed clinical data from its Phase 1 trial of INB-200 in The Journal of Clinical Oncology (JCO), one of the most prestigious oncology journals.
The publication, titled: “Intracranial injection of ex vivo expanded and activated gamma-delta T cells engineered with a MGMT-expressing lentivector in patients with primary glioblastoma,” reports results from the first-in-human study of an autologous, genetically modified γδ T cell therapy. The expanded, activated γδ T cells are engineered to be resistant to chemotherapy (DeltEx DRI) and delivered intracranially in combination with standard of care (SOC) temozolomide chemotherapy (TMZ).
The Phase 1 trial is a frequency-escalation study of DeltEx DRI in GBM patients in combination with the SOC Stupp regimen (surgical resection followed by chemoradiation and maintenance chemotherapy). A total of 13 patients were enrolled and treated across three cohorts with subjects in their respective cohorts receiving 1, 3, or up to 6 doses of DeltEx DRI in 28-day cycles during maintenance chemotherapy. Evaluations included the safety and feasibility of repeated intracranial administration during maintenance chemotherapy.
GBM is the most common malignant primary brain tumor in adults and one of the most aggressive and difficult cancers to treat, with overall survival of only ~11 months and a five-year survival of ~5%. Despite overall advances across numerous cancer therapies, survival in GBM has been almost unchanged in more than 20 years with no new drug approvals and only a single device approval. Recurrence is nearly universal with GBM patients facing rapid decline, very limited treatment options, and poor outcomes.
In the Phase 1 study, DeltEx DRI in combination with SOC demonstrated a well-tolerated safety profile with no DLTs, no cytokine release syndrome (CRS), and no immune effector cell-associated neurotoxicity (ICANS) observed. The therapy also showed compelling signals of clinical activity. Across all 13 treated patients, mPFS was 9.9 months, and a 43.5% improvement over the 6.9 months typically reported with SOC alone. The results were most striking in repeat-dose patients (those receiving 3 to 6 doses) where mPFS reached 16.1 months, more than double the SOC benchmark. Overall survival (OS) was equally notable: median OS in repeat-dose patients was 19.5 months, compared to a historical SOC mOS of approximately 14.6 months in this patient population.
“These peer-reviewed results validate the scientific foundation of our DeltEx platform and highlight the transformative potential of γδ T cells in treating solid tumors,” said William Ho, Chief Executive Officer and Co-founder of IN8bio. “Glioblastoma remains one of the most devastating cancers, and patients urgently need new treatment options. By enabling immune cells to remain active alongside conventional chemotherapy and delivering them directly to the tumor, DeltEx DRI is designed to drive meaningful synergies, improve patient outcomes, and change the treatment paradigm for this disease.”
“Publication in The Journal of Clinical Oncology represents a significant milestone for this program and for the broader effort to bring effective immunotherapies to patients with glioblastoma,” said Burt Nabors, M.D., Professor of Neurology, Director of Neuro-Oncology at the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, and lead investigator of the study. “This trial demonstrates that intracranial delivery of chemotherapy-resistant γδ T cells is feasible and well tolerated. The encouraging signals of prolonged disease control and absence of immune-mediated toxicity, particularly with repeated dosing, provide a compelling rationale for continued clinical development of this novel therapeutic approach.”
Despite aggressive SOC treatment, residual tumor cells persist in nearly all GBM patients, a key reason the disease remains almost universally fatal. The DeltEx DRI technology directly addresses this challenge: γδ T cells are engineered to resist being killed by the chemotherapy that is administered concurrently, then delivered intracranially to the tumor site, where they can attack residual cancer cells and potentially achieve deeper, more durable tumor responses. These JCO-published results offer meaningful evidence that this strategy can extend disease control in these patients with significant unmet need and support its continued advancement as a potential new treatment paradigm for solid tumors. IN8bio expects to provide additional updates to the DeltEx DRI program in newly diagnosed GBM later this year.
About INB-200 and INB-400 (DeltEx™ Drug Resistant Immunotherapy)
INB-200 and INB-400 are an autologous, genetically modified gamma-delta T cell therapy engineered with an MGMT-expressing lentivector designed to resist alkylating chemotherapy. The therapy is administered intracranially and is intended to work in combination with temozolomide to target residual tumor cells, enhance immune activation, and prolong disease control in patients with glioblastoma.
About IN8bio
IN8bio is a clinical-stage biopharmaceutical company developing γδ T cell and γδ T cell engager (TCE) product candidates to address unmet medical needs. γδ T cells are a specialized population of T cells that possess unique properties, including the ability to differentiate between healthy and diseased tissue. The Company’s pipeline is anchored by INB-600, a novel γδ T cell engager platform with potential applications across oncology and autoimmune indications. IN8bio is also advancing INB-100, an allogeneic γδ T cell candidate for adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation, and INB-200/400, an autologous genetically modified γδ T cell candidate for newly diagnosed glioblastoma (GBM). For more information about IN8bio, visit www.IN8bio.com.
Forward-Looking Statements
This press release may contain forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will” and variations of these words or similar expressions that are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Forward-looking statements in this press release include, but are not limited to, statements regarding: the therapeutic potential of IN8bio’s product candidates; the potential of DeltEx DRI γδ T cell therapy to improve outcomes in patients with newly diagnosed glioblastoma; IN8bio’s ability to achieve anticipated milestones, including continued clinical development and regulatory engagement; and other statements that are not historical fact. IN8bio may not actually achieve the plans, intentions or expectations disclosed in these forward-looking statements, and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from those anticipated as a result of various factors, including: risks to clinical trial progress, patient enrollment and follow-up; uncertainties inherent in the initiation and completion of clinical trials; whether outcomes from prior studies will be predictive of future clinical results; and other important factors described in greater detail in the section entitled “Risk Factors” in IN8bio’s most recent filings with the Securities and Exchange Commission (SEC). Any forward-looking statements contained in this press release speak only as of the date hereof, and IN8bio expressly disclaims any obligation to update any forward-looking statements contained herein, except as otherwise required by law.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
PITTSBURGH--(BUSINESS WIRE)--Intelligent power management company Eaton today announces a collaboration with FranklinWH to make intelligent, flexible home energy systems easier to buy, install and scale across North America. The integration of Eaton's AbleEdge™ smart breakers with the FranklinWH System helps improve energy affordability by enabling more flexible, intelligent and simplified energy management at home. The companies will help make it easier for contractors and homeowners to integr.
SWORDS, Ireland--(BUSINESS WIRE)--Trane Technologies plc (NYSE:TT), a global climate innovator, will host a conference call to discuss its second quarter 2026 financial results on Thursday, July 30, 2026, at 10 a.m. ET. The company will issue its second quarter earnings release and earnings presentation in advance of the call; both will be available on the Trane Technologies website. A real-time, listen-only webcast of the conference call will be broadcast live over the internet. Individuals wi.
Trane Technologies plc (NYSE: TT), a global climate innovator, will host a conference call to discuss its second quarter 2026 financial results on Thursday, Jul
Strategic Education is shifting from low-margin B2C to high-margin edtech, emphasizing employer-affiliated partnerships and recurring SaaS-like revenues. The ETS segment now generates 46% of operating income, with Workforce Edge and Sophia Learning driving 21% and 32% revenue growth, respectively, and margins reaching 47%. I assign STRA a Strong Buy rating with a $117/share target, reflecting a rerating opportunity as recurring tech segment profits rise and multiples approach SaaS peers.
SAN DIEGO, July 09, 2026 (GLOBE NEWSWIRE) -- LPL Financial Holdings Inc. (Nasdaq: LPLA) today announced that its firms earned the #1 and #2 rankings in the JD Power 2026 U.S. Financial Advisor Satisfaction Study in the category of “Independent Advisor Satisfaction Among Financial Investment Firms.” Commonwealth Financial Network, acquired by LPL in 2025, secured its 13th consecutive #1 ranking, while LPL Financial LLC rose to #2 overall.
The results reflect a system intentionally built around advisor success — one that combines Commonwealth’s long-standing model of deeply personalized service with LPL’s scale, innovation and expanding capabilities. Together, the firms represent the top two ranked experiences for independent advisors in the industry.
Commonwealth’s continued recognition underscores the consistency of a model designed around the advisor experience and refined over time to meet evolving needs. In the 2026 study, Commonwealth achieved the highest scores across the majority of key drivers of satisfaction, including compensation, firm leadership and culture, professional development, products and marketing, and operational support.
“These results are a powerful demonstration of our shared commitment to putting advisors at the center of everything we do,” said Rich Steinmeier, CEO of LPL. “Commonwealth’s extraordinary 13-year streak reflects a model built with intention — one that is deeply grounded in service, relationships and advisor partnership. At the same time, LPL’s position as the #2 ranked firm underscores the strength of an advanced technology platform, wide range of affiliation models and extensive wealth management offerings. Together, both organizations create an unmatched environment for advisor success.”
With both firms ranked at the top of the study segment, the combined organization reflects more than parallel achievement; it demonstrates a shared philosophy and aligned purpose. LPL remains committed to preserving the distinct strengths of Commonwealth while investing in expanding choice, flexibility and resources for advisors across the platform.
This approach enables advisors to benefit from a spectrum of affiliation models, integrated wealth management solutions, and a service experience that seeks to support their success and that of their clients. The JD Power 2026 U.S. Financial Advisor Satisfaction Study measures advisor satisfaction across key dimensions including compensation; firm leadership and culture; operational support; products and marketing; professional development; and technology.
About LPL Financial
LPL Financial Holdings Inc. (Nasdaq: LPLA) is among the fastest growing wealth management firms in the U.S. As a leader in the financial advisor-mediated marketplace, LPL supports more than 32,000 financial advisors and the wealth management practices of approximately 1,100 financial institutions, servicing and custodying approximately $2.3 trillion in brokerage and advisory assets on behalf of approximately 8 million Americans. The firm provides a wide range of advisor affiliation models, investment solutions, fintech tools and practice management services, ensuring that advisors and institutions have the flexibility to choose the business model, services, and technology resources they need to run thriving businesses. For further information about LPL, please visit www.lpl.com/.
Securities and advisory services offered through LPL Financial LLC (“LPL Financial”), a registered investment adviser and broker-dealer. Member FINRA/SIPC.
Throughout this communication, the terms "financial advisors" and "advisors" are used to refer to registered representatives and/or investment advisor representatives affiliated with LPL Financial.
, /PRNewswire/ -- Howmet Aerospace Inc. (NYSE: HWM) will announce its second quarter 2026 financial results on Thursday, August 6, 2026. The press release and presentation materials will be available at approximately 7:00 AM ET on August 6, 2026, via the "Investors" section of the Howmet Aerospace website.
The conference call and webcast will begin at 10:00 AM ET. Details of both follow.
Conference Call Information:
Day:
Thursday, August 6, 2026
Time:
10:00 AM ET
Hosts:
John Plant, Executive Chairman and Chief Executive Officer
Patrick Winterlich, Executive Vice President and Chief Financial Officer
Call:
U.S./Canada Toll Free: + 1-844-481-2703
International Toll: + 1-412-317-0659
Participants may pre-register for the conference call at:
https://dpregister.com/sreg/10205417/102ffa34708
Webcast:
Available on the "Investors/Events and Presentations" section of www.howmet.com
(audio and slides).
Replay Information
A webcast replay of the call will be available on the "Investors/Events and Presentations" section of www.howmet.com. Telephone replay of the call will be available from two hours after the conclusion of the live call until August 20, 2026, at 11:59 PM ET. Details follow.
Replay:
USA Toll Free/Canada:
1-855-669-9658
International Toll:
1-412-317-0088
Replay Access Code:
6310452
Or access via the "Investors/Events and Presentations" section of www.howmet.com
About Howmet Aerospace
Howmet Aerospace Inc., headquartered in Pittsburgh, Pennsylvania, is a leading global provider of advanced engineered solutions for the aerospace, gas turbine, and transportation industries. The Company's primary businesses focus on engine components, fastening systems, and airframe structural components necessary for mission-critical performance and efficiency, including in aerospace, defense, and gas turbine applications, as well as forged aluminum wheels for commercial transportation. With approximately 1,200 granted and pending patents, the Company's differentiated technologies enable lighter, more fuel-efficient aircraft and commercial trucks to operate with a lower carbon footprint.
For more information, visit www.howmet.com.
Dissemination of Company Information
Howmet Aerospace intends to make future announcements regarding Company developments and financial performance through its website at www.howmet.com.
This expansion of IV solutions manufacturing will help enhance supply-chain resiliency, support portfolio development and advance non-DEHP innovation for the North American IV solutions market.
Joint venture announces over $500M IV solutions manufacturing expansion in Austin, TX Expansion aimed at improving IV solutions supply resiliency and quality, and accelerating non-DEHP new product development in North America via fully automated technology First major milestone toward fulfilling the commitments of the joint venture finalized in May 2025 between ICU Medical, Inc. and Otsuka Pharmaceutical Factory America, Inc. , /PRNewswire/ -- Otsuka ICU Medical LLC today announced plans for an over $500 million expansion to its US IV solutions manufacturing through a new facility and significant upgrades to its existing operations in Austin, Texas. The expansion is expected to enhance long-term supply resiliency and accelerate new product development while positioning the portfolio to support evolving non-DEHP legislation across the North American IV solutions market.
The project will leverage Otsuka Pharmaceutical Factory, Inc.'s long-standing expertise in IV container development and manufacturing quality to support Otsuka ICU Medical LLC's advancement of non-DEHP IV solutions for the North American market. As part of this initiative, Otsuka ICU Medical LLC will expand its existing 700,000-square-foot Austin manufacturing site with a new 500,000-square-foot facility in Austin to support greater operational flexibility and future innovation across IV solutions and specialty pharmaceutical segments.
This expansion is the first major milestone toward delivering on the commitments made by the joint venture between ICU Medical, Inc. and Otsuka Pharmaceutical Factory America, Inc., a subsidiary of Otsuka Pharmaceutical Factory, Inc., finalized in May 2025. It reflects the partnership's strategic focus on bolstering North American IV solutions manufacturing and innovation, while complementing existing efforts to obtain long-term FDA approval of select overseas Otsuka manufacturing sites to supplement North American supply as needed.
"This expansion reflects our commitment to long-term growth in a clinically essential market," said Yoshifumi Fujimoto, chief executive officer of Otsuka ICU Medical LLC. "By strengthening our US manufacturing footprint, expanding non-DEHP capabilities, and introducing innovation, we are enhancing supply reliability for North American customers while positioning ourselves to better support future regulatory and legislative requirements."
The North American IV solutions market remains highly concentrated, and recent supply chain disruptions—driven by natural disasters and infrastructure constraints—have highlighted the importance of resilient, geographically diversified production. At the same time, healthcare providers are preparing for an evolving regulatory environment, including the transition toward non-DEHP IV solutions containers. This expansion is designed to address both needs: strengthening supply resiliency while supporting future portfolio innovation and market readiness.
Media Contact:
Harrison Richards, ICU Medical, Inc.
949-366-4261
[email protected]
About Otsuka ICU Medical LLC.: Otsuka ICU Medical LLC is a joint venture between ICU Medical, Inc. and Otsuka Pharmaceutical Factory America, Inc., subsidiary of Otsuka Pharmaceutical Factory, Inc., formed to strengthen the resiliency, reliability, and innovation of IV solutions supply in North America. Combining global manufacturing scale with strong North American production and distribution capabilities, Otsuka ICU Medical LLC supports caregivers with high-quality IV solutions designed to help deliver safe, consistent patient care. For more information, visit www.otsukaicumed.com.
About Otsuka Pharmaceutical Factory, Inc. (OPF): OPF is the original company from which the Otsuka Group has grown. The management vision of OPF is "the best partner in clinical nutrition worldwide", and as a leading company in IV solutions in Japan has been developing, manufacturing, and selling IV solutions for 80 years. Today, in addition to IV solutions, OPF provides a variety of products that contribute to solving issues in the healthcare setting. For more information, visit https://www.otsukakj.jp/en/.
About Otsuka Pharmaceutical Factory America, Inc. (OPFA): OPFA operates across healthcare and life sciences markets engaging in the research, development, technology transfer, manufacture, and sale and importation of pharmaceuticals, IV solutions, medical devices and functional food products. The company also oversees the management and strategic operations of its U.S. subsidiary, Otsuka ICU Medical LLC, and related business activities.
About ICU Medical: ICU Medical, Inc. (Nasdaq: ICUI) offers clinically essential medical devices that connect patients and caregivers through life-enhancing, innovative technology and services that provide meaningful clinical value. The organization's robust portfolio features medical delivery systems and consumable products for infusion therapy, emergency medicine, general and regional anesthesia, home care, NICU/PICU, oncology, pain management, and respiratory care. More information about ICU Medical, Inc. can be found at www.icumed.com.
SummaryThis is an auspicious time to invest in REITs outyielding the no-risk rate by 100 bps or more.This article presents 3 Net Lease REITs that offer compelling yields, strong balance sheets, positive growth prospects, and favorable valuations.All 3 companies demonstrate superb occupancy, stable triple-net lease structures, and steady dividend growth, with yields outpacing Treasuries by 100 - 200 basis points.Key risks include potential macro headwinds such as recession or rising rates.Looking for a portfolio of ideas like this one? Members of iREIT®+HOYA Capital get exclusive access to our subscriber-only portfolios. Learn More » Getty Images
This continues to be an auspicious time to invest in REITs, particularly those that outyield the no-risk rate by 100 bps or more, and/or enjoy a favorable supply/demand environment. Despite . . .
the rise in the 3K Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of BNL, EPR, GTY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
A Buy, Sell, or Hold rating in this article does not constitute a Buy, Sell, or Hold recommendation. All investors should exercise their own due diligence, before investing in any stock.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
DENVER, July 09, 2026 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a leader in the Nutritional Snacking Category, today reported financial results for the thirteen and thirty-nine weeks ended May 30, 2026. Third Quarter Summary: (1) Net sales of $357.0 million versus $381.0 million Net loss of $52.0 million versus net income of $41.1 million Loss per diluted share of $0.58 versus earnings per diluted share of $0.40 Adjusted Diluted EPS (2) of $0.42 versus $0.51 Adjusted EBITDA (3) of $57.2 million versus $73.9 million Updating Fiscal Year 2026 (4) Outlook: Net sales expected to range between $1.345 and $1.355 billion, or a decline of roughly 7% to 6% year-over-year Gross margins expected to decline approximately 375 basis points year-over-year Adjusted EBITDA expected to range between $220 and $225 million, or -21% to -19% year-over-year “Our third quarter results reflect initial steps against the turnaround priorities we outlined last quarter.
Nové žádosti o podporu v nezaměstnanosti (4. července):
aktuální hodnota: 215 tis.
očekávání trhu: 217 tis.
předchozí hodnota: 215 tis. / revize: 217 tis.
Pokračující žádosti o podporu v nezaměstnanosti (27. června):
aktuální hodnota: 1814 tis.
očekávání trhu: 1814 tis.
předchozí hodnota: 1814 tis. / revize: 1806 tis.
July 09, 2026 07:30 ET | Source: FTI Consulting, Inc.
WASHINGTON, July 09, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results for the second quarter ended June 30, 2026, before the New York market opens on Thursday, July 30, 2026.
A conference call will be held to discuss these financial results on Thursday, July 30, 2026, at 9:00 a.m. Eastern Time and will be hosted by senior management.
The conference call will be simulcast live on the Internet and can be accessed by logging onto the Company's investor relations website. A replay of the webcast will be available on the Company's investor relations website for 90 days.
About FTI Consulting
FTI Consulting, Inc. is a leading global expert firm for organizations facing crisis and transformation, with more than 8,100 employees located in 32 countries and territories as of March 31, 2026. In certain jurisdictions, FTI Consulting’s services are provided through distinct legal entities that are separately capitalized and independently managed. The Company generated $3.8 billion in revenues during fiscal year 2025. More information can be found at www.fticonsulting.com.
FTI Consulting, Inc.
555 12th Street NW
Washington, DC 20004
+1.202.312.9100
The Euro (EUR) retreats to near 1.1425 against the US Dollar (USD) during the European trading session on Thursday. The major currency pair falls back as the US Dollar claws back a majority of its early losses, with the appeal of safe-haven assets improving in the wake of renewed geopolitical risks.
As of writing, the US Dollar Index (DXY), which gauges the Greenback’s value against six major currencies, trades marginally lower around 101.00 after rebounding from the day’s low of 100.80.
The exchange of attacks between the United States (US) and Iran, following confirmation from President Donald Trump that the Memorandum of Understanding (MoU) with Iran is over, has lifted the safe-haven demand.
The US military forces have also attacked Iranian infrastructure, which suggests that tensions could remain prolonged.
Higher oil prices due to diminished traffic near the Strait of Hormuz have de-anchored inflation expectations again, a scenario that could discourage Federal Reserve (Fed) officials further from reducing interest rates this year.
The Federal Open Market Committee (FOMC) Minutes of the June policy meeting, released on Wednesday, also showed that policymakers continue to see “inflation as the dominant risk”, and several officials still believe further tightening could become necessary.
Meanwhile, traders have raised hawkish European Central Bank (ECB) as oil prices have increased significantly after the US-Iran went back to square.
According to a Reuters report, traders have priced in another 30 basis points (bps) increase in policy rates this year. In June, the ECB raised its key rates by 25 bps.
US Dollar FAQs The US Dollar (USD) is the official currency of the United States of America, and the ‘de facto’ currency of a significant number of other countries where it is found in circulation alongside local notes. It is the most heavily traded currency in the world, accounting for over 88% of all global foreign exchange turnover, or an average of $6.6 trillion in transactions per day, according to data from 2022. Following the second world war, the USD took over from the British Pound as the world’s reserve currency. For most of its history, the US Dollar was backed by Gold, until the Bretton Woods Agreement in 1971 when the Gold Standard went away.
The most important single factor impacting on the value of the US Dollar is monetary policy, which is shaped by the Federal Reserve (Fed). The Fed has two mandates: to achieve price stability (control inflation) and foster full employment. Its primary tool to achieve these two goals is by adjusting interest rates. When prices are rising too quickly and inflation is above the Fed’s 2% target, the Fed will raise rates, which helps the USD value. When inflation falls below 2% or the Unemployment Rate is too high, the Fed may lower interest rates, which weighs on the Greenback.
In extreme situations, the Federal Reserve can also print more Dollars and enact quantitative easing (QE). QE is the process by which the Fed substantially increases the flow of credit in a stuck financial system. It is a non-standard policy measure used when credit has dried up because banks will not lend to each other (out of the fear of counterparty default). It is a last resort when simply lowering interest rates is unlikely to achieve the necessary result. It was the Fed’s weapon of choice to combat the credit crunch that occurred during the Great Financial Crisis in 2008. It involves the Fed printing more Dollars and using them to buy US government bonds predominantly from financial institutions. QE usually leads to a weaker US Dollar.
Quantitative tightening (QT) is the reverse process whereby the Federal Reserve stops buying bonds from financial institutions and does not reinvest the principal from the bonds it holds maturing in new purchases. It is usually positive for the US Dollar.
The British Pound (GBP) is pulling lower against the Japanese Yen (JPY) on Thursday, after hitting a fresh all-time high at 218.01 earlier on the day. The pair has returned to the mid-range of the 217.00s at the time of writing, yet with the bullish trend in place, holding comfortably above the previous highs, in the 217.20 area.
Risks of an intervention by the Japanese authorities remain high, but the wide divergence between the Bank of Japan’s (BoJ) interest rates and those of the major central banks poses a heavy weight on the JPY. More so with Oil prices bouncing up and pressuring global central banks to tighten their borrowing costs.
Technical Analysis: RSI divergence hints at a potential correction
GBP/JPY trades at 217.60, with Elliott Wave analysis suggesting that the pair might be on the fifth and last wave of a bullish cycle. The Pound has pulled back from the 127.2% Fibonacci extension of the fourth wave, at 218.00, and the bearish divergence in the four-hour Relative Strength Index suggests that some consolidation or a corrective reversal might follow from here.
Bears, however, should break the July 7 lows, at 216.35, to confirm that the bullish cycle has completed. In that case, the early July trading floor, near 214.65, would emerge as the next target.
The broader bias, on the other hand, remains positive, and bulls might attempt a further rally, heading for the 261.8% Fibonacci extension of the mentioned rally, at 218.90. Furter appreciation seems off the cards right now.
(The technical analysis of this story was written with the help of an AI tool. Know more.)
Japanese Yen Price Today The table below shows the percentage change of Japanese Yen (JPY) against listed major currencies today. Japanese Yen was the strongest against the Canadian Dollar.
USDEURGBPJPYCADAUDNZDCHFUSD-0.08%-0.00%-0.08%0.05%-0.05%-0.59%-0.12%EUR0.08%0.08%0.00%0.12%0.05%-0.49%-0.03%GBP0.00%-0.08%-0.09%0.05%-0.03%-0.56%-0.11%JPY0.08%0.00%0.09%0.11%0.06%-0.51%-0.04%CAD-0.05%-0.12%-0.05%-0.11%-0.07%-0.61%-0.15%AUD0.05%-0.05%0.03%-0.06%0.07%-0.53%-0.08%NZD0.59%0.49%0.56%0.51%0.61%0.53%0.46%CHF0.12%0.03%0.11%0.04%0.15%0.08%-0.46% The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the Japanese Yen from the left column and move along the horizontal line to the US Dollar, the percentage change displayed in the box will represent JPY (base)/USD (quote).
RaboResearch Global Economics & Markets discusses how Euro sentiment has cooled after optimism around Germany’s debt brake, with political risks and structural headwinds weighing on the currency. The bank notes EUR/USD is already priced for another ECB hike and expects sideways trading near current levels in the coming months, with only a modest upward bias further out.
Euro sentiment cools after 2025 surge"While higher short-term interest rates are currency supportive, the market is already fully priced for another ECB rate hike this year, suggesting that one more policy move is unlikely to offer much support for the EUR. On balance, we expect EUR/USD to trade sideways close to current levels on a 1-to-3-month view."
"Irrespective of this, it is worth noting that the EUR was the second best performing G10 currency in Q2 2025 after the safe haven CHF. This highlights the part the EUR played in emphasising the sharp rise in the EUR/USD in that period."
"The EUR now appears to have lost that momentum and that has clear implications for the outlook for EUR/USD."
"In our view, the market is likely to be reluctant to rebuild large, long positions in the EUR in the months ahead. That said, while the USD has benefited from a resilient US economy, it is RaboResearch’s view that hawkish bets on the Fed are overdone."
"We expect sideways trading in EUR/USD on a 3-month view and a modest upward bias to emerge in the currency pair on a 3-to-6-month view."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor. Know more.)
EURGBP holds within narrow consolidation on Thursday after hitting new over one year low in strong bearish acceleration in past couple of sessions.
The pair is also on track for the third consecutive strong weekly loss, as Sterling continues to benefit from calmer political situation after resignation of PM Starmer (although still with a lot of uncertainty about potential new PM Burnham’s policies and cabinet members).
Strongly oversold conditions on daily chart suggest that bears may pause for consolidation / limited correction, as larger bears remain firmly in play.
Initial resistance lays at 0.8543 (broken Fibo 50% retracement of 0.8222/0.8865) and 0.8553 (broken 100WMA / weekly cloud base) with weekly close below these levels to reinforce broader bearish structure.
Stronger upticks, on the other hand, should stay capped under 0.8600 zone (falling 20DMA / former higher base) to provide better selling levels for fresh push lower.
The information contained in this document was obtained from sources believed to be reliable, but its accuracy or completeness cannot be guaranteed. Any opinions expressed herein are in good faith, but are subject to change without notice. No liability accepted whatsoever for any direct or consequential loss arising from the use of this document.
Listen below or on the go via Apple Podcasts and Spotify
Levi beat on revenue and profit. (00:13) Shares fell anyway. Monster sets the date for a 2-for-1 split. (01:33) Burry bets on betting. (02:05)
This is an abridged transcript.
Shares of Levi Strauss & Co. (LEVI) are under pressure.
LEVI reported a top- and bottom-line beat in the second quarter but it was overshadowed by the company’s conservative outlook for the fiscal year that continued to reflect significant headwinds from import tariffs.
As the company pivots to a direct-to-consumer-focused business model, an 11% increase in DTC sales and solid gains in U.S., Europe, and Asian sales contributed to $1.56B in total revenue, an increase of 7.6% year-over-year and $80M better than expected. Wholesale sales were up 5%.
The company’s bottom-line improved as well, with adjusted net income increasing 24% to $110M, or $0.28 per share, 4 cents above expectations.
Looking ahead to the remainder of 2026, Levi’s (LEVI) outlook left investors disappointed that Q2 results did not lead to a larger upward revision. In addition, the company warned that 2026 guidance assumes U.S. tariffs on imports from China remain at 30% and 20% for rest-of-world.
Shares are down 6% in early trading.
Monster Beverage (MNST) announced that its board of directors has approved and declared a 2-for-1 split of its common stock.
Each stockholder of record on July 24, 2026 will receive a dividend of one additional share of common stock for each then-held share, to be distributed after close of trading on August 10, 2026.
Monster anticipates its common stock to begin trading at the split-adjusted price on August 11, 2026.
MNST closed the day Wednesday at $95.15.
Shares of DraftKings (DKNG) and Flutter (FLUT) both moved higher after Michael Burry disclosed a new stake in both online betting platforms in a Substack post.
Burry posted that, “DraftKings is inflecting as an operating business, and the value is in the transition I foresee in the near future.” He goes on to say, “Flutter has been hurt by capital misallocation in the past but is fundamentally a very good operating business with terrific scale.”
While Burry acknowledges the threat from prediction markets and their impact on the share price of DraftKings (DKNG) and Flutter (FLUT), he says prediction markets like Kalshi (KALSHI) and Polymarket (POLYMARKET) will eventually be “subsumed into regulation and taxation.”
What’s Trending on Seeking Alpha
SK Hynix US listing said to be over seven times oversubscribed
Multistate lawsuit in Paramount/Warner Bros. deal expected next week - CTFN
Judge approves Elon Musk's settlement with SEC in Twitter case despite 'misgivings'
Stock index futures are higher before the opening bell.
Crude oil is down 0.75% at just under $73. Bitcoin is up 0.9% at $62,000. Gold is up 0.8% at $4,108.
The FTSE 100 is down 0.5% and the DAX is up 0.25%.
One stock on the biggest movers list: Ampco-Pittsburgh (AP) +14% - Shares jumped after the company reported H1 2026 customer orders rose 32% Y/Y to $268M, driven by strength across both operating segments.
1. AZN Sinks as Heart Drug Fails Test Target AstraZeneca (AZN 1.92%) fell over 8% ahead of the opening bell after a late-stage clinical trial for its heart disease drug Wainua failed to meet its target, with the stock down on the potential impact it could have on profitability.
Wainua "did not provide a statistically significant benefit": The drug is designed to help a condition that affects between 300,000 and 500,000 people globally, and marks the second recent setback for the Team Rule Breakers recommendation following the approval delay from U.S. regulators for a new cancer treatment back in May. The drugmaker reported 16 positive late-stage trial results last year: In November, Fool analysts including Asit Sharma, Karl Thiel, and Jason Moser explained the business "wants to get even further ahead," and said there's the "potential for quantum computing and other technological innovation to have a massive positive impact on drug development." 2. Diverging Earnings Reaction From LEVI, PSMT, and AZZ Levi Strauss (LEVI 1.18%) dropped around 6% before the market opened despite quarterly revenue and earnings beating expectations, as the full-year revenue guidance increase didn't impress investors enough, with some concern around tariffs and costs going forward. PriceSmart (PSMT 1.48%) was little changed ahead of the opening bell following a mixed bag of results. Earnings per share missed consensus, but investor sentiment was boosted with plans for global expansion into Chile. AZZ (AZZ 0.31%) popped almost 8% in pre-market trading thanks to results showing high industrial demand for metal coatings. The Team Hidden Gems recommendation also raised the full-year outlook.
3. Fed Minutes Unveil Rate Divisions
The Federal Reserve's June meeting minutes revealed policymakers entertained different scenarios for interest rates going forward, although ambiguity around the competing views meant the immediate impact on the stock market was muted.
"Participants noted that their future policy actions would depend on incoming information": Voting members noted the risks of higher inflation, but balanced this with the need to monitor the impact of the situation in the Middle East for any easing in energy price disruption. 14-page meeting summary shorter than typical release: In line with new Fed Chair Warsh's statement that Fed officials should communicate less about future policy intentions, the meeting minutes were balanced without providing more guidance than previously offered. 4. SK Hynix Draws Giant U.S. ADR Demand Bloomberg reports the U.S. listing for Korean memory chipmaker SK Hynix is more than seven times oversubscribed, as the offering could be set to rank among the largest ever debuts by a foreign company.
High institutional demand noted: The listing, via American depositary receipts (ADRs), has attracted a lot of interest from sovereign wealth funds and more traditional asset managers who will be able to get exposure more easily in a U.S. marketplace. The offering could raise about $24.5 billion: Based on Bloomberg calculations, the share equivalent of the ADR means the funds raised would rank second only to the $25 billion raised by Alibaba (BABA +10.96%) back in 2014. 5. Today's Take: Credit Where It's Due
I like how Carol Tomé, the CEO of UPS (UPS 1.80%), thinks about it. She has said she wants her legacy judged by the leadership team she leaves behind when she retires. Valuations and market cycles are largely outside a CEO's control. The people and culture they build are not.-- Anthony Schiavone
The founder who is responsible for the company's product, brand, and vision is immensely responsible for success. A CEO who creates a new vision and turns a company around is a massive contributor. But there are also cases where a business thrives or survives in spite of its leadership, simply because the product is so important or because the environment is easy to navigate.-- Alicia Alfiere Team Rule Breakers
6. Your Take Which, if any, positions have you sold all or some of from your portfolio in the last month, and why?
Share with friends and family, or become a member to hear what your fellow Fools are saying!
This image and article was created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool has positions in and recommends AstraZeneca Plc, Azz, and United Parcel Service. The Motley Fool recommends Alibaba Group. The Motley Fool has a disclosure policy.
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Thursday.
Shares of Levi Strauss & Co (NYSE:LEVI) fell sharply in pre-market trading following second-quarter results.
The company reported quarterly earnings of 28 cents per share, which beat the analyst consensus estimate of 24 cents per share. The company reported quarterly sales of $1.562 billion, which beat the analyst consensus estimate of $1.520 billion.
Levi Strauss shares dipped 6.1% to $22.89 in pre-market trading.
Here are some other stocks moving lower in pre-market trading.
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
JERUSALEM--(BUSINESS WIRE)--Mobileye Global Inc. (Nasdaq: MBLY) (“Mobileye”) today announced that it will release its financial results for the second quarter 2026 on Thursday, July 23rd, 2026, before market open. Mobileye will host a conference call at 8:00am ET (3:00pm IT) to review its results and provide a general business update. The call will be hosted by Professor Amnon Shashua, CEO, Moran Shemesh Rojansky, CFO, Nimrod Nehushtan, EVP – Business Development and Strategy, and Dan Galves, C.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The GLP-1 trade has matured from a single-stock story into a tiered opportunity set. Demand for obesity therapeutics keeps expanding as lower-cost, easier-to-administer oral pill versions of the current injectable GLP-1s are introduced to the market in 2026, and the field now spans an entrenched leader, a deep-value incumbent, and a clinical-stage challenger with multiple near-term catalysts. Heading into July, here are three US-listed GLP-1 names worth a closer look, each with a tool-verified data point, a bull case, and a clear risk.
Eli Lilly (LLY): The Category Killer Eli Lilly (NYSE:LLY | LLY Price Prediction) is the franchise stock of the GLP-1 era, and the price action reflects it. Shares are up nearly 15% year to date and more than 60% over the past year, with a market cap of roughly $1.16 trillion as of July 7.
Q1 2026 was a statement quarter. Lilly posted EPS of $8.55 versus the $6.79 consensus on revenue of $19.80 billion, up 56% year over year. Mounjaro generated $8.66 billion (+125% YoY) and Zepbound delivered $4.16 billion (+80% YoY). Management raised full-year guidance to $82.0 billion to $85.0 billion in revenue and $35.50 to $37.00 in non-GAAP EPS.
The bull case rests on a one-two punch: injectable dominance plus the only oral pill with no food/water restriction. CEO David Ricks said “A key milestone was the U.S. FDA approval of Foundayo, the only approved GLP-1 pill that can be taken any time of day, without food and water restrictions. Foundayo will meaningfully expand the number of people who can benefit from GLP-1s.”
Risk: Realized prices fell 13% in Q1 2026 due to rebate adjustments and market-access agreements, and Mounjaro’s NRDL addition in China is pressuring international pricing. Revenue concentration in two products remains the obvious vulnerability.
Novo Nordisk (NVO): The Beaten-Down Incumbent Novo Nordisk (NYSE:NVO) is the contrarian pick. The maker of Ozempic, Wegovy and Rybelsus is down nearly 28% over the past year, with a market cap of around $169 billion. Per writer context, shares trade at roughly 10x earnings and sit near 45% below their 52-week high. Note that NVO is an ADR, so dividends are subject to Danish withholding tax at source.
Sentiment is beginning to shift. Reddit’s aggregate score on NVO flipped to 63 (Bullish) on June 30, up from readings of 22-29 (Bearish) in early June, and shares have rebounded more than 2% over the past month.
The bull case is valuation-driven. NVO posts elite margins (gross margin near 81%, operating margin around 41%) and remains one of only two players with a commercial oral GLP-1 already on the market. If the company stabilizes US share against Lilly, mean reversion alone offers material upside.
SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now.
Risk: Novo has been steadily losing ground to Mounjaro and Zepbound, and Jim Cramer recently noted Lilly’s pipeline could deliver “the unassailable knockout punch against Novo Nordisk because it’s got fat busting without muscle crunch.” A value trap is the obvious failure mode.
Viking Therapeutics (VKTX): The High-Risk Wild Card Viking Therapeutics (NASDAQ:VKTX) is explicitly the speculative slot. Market cap sits at about $4.7 billion, and shares have rallied nearly 38% over the past month, with a one-year gain of nearly 47%.
Lead asset VK2735 is a dual GLP-1/GIP receptor agonist in both subcutaneous and oral formulations. The Phase 2 oral readout showed up to 12% mean body weight reduction after 13 weeks. VANQUISH-1 is fully enrolled with approximately 4,500 patients, and the Phase 3 oral program is expected to begin in Q3 2026, with maintenance dosing results also due that quarter. Cash and investments stood at roughly $706 million at year-end 2025.
CEO Brian Lian framed the differentiation as “the only dual agonist molecule with the potential to dose monthly or to allow transition from subcutaneous to oral administration for weight maintenance.”
Risk: Viking is pre-revenue, with a 2025 net loss of $359.64 million and a cash position that fell from $903 million at the start of 2025 to $706 million at year-end. Phase 3 readouts could land either way, and a single negative trial would reset the equity story.
What to Watch Next July’s setup is event-rich: Lilly’s Foundayo launch metrics, Novo’s competitive response, and Viking’s Q3 catalyst calendar. Position sizing matters across the three, because the risk profiles are not interchangeable. The GLP-1 trade is broadening, and the opportunity set looks wider than at any point in the last twelve months.
Want Up To $1,000? SoFi Is Giving New Active Invest Users Free StockLooking to grow your money but unsure where to begin? SoFi Active Invest is offering a limited-time promotion—open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts.
From $0 commission trading to fractional shares and automated investing, this app is designed to simplify investing for everyone, whether you’re just starting or already experienced. Its easy to sign up and secure your bonus.
LONDON, July 09, 2026 (GLOBE NEWSWIRE) -- Marex Group Limited (‘Marex’ or the ‘Group’; NASDAQ: MRX), the diversified global financial services platform, today announces it has agreed to acquire Bright Point International (‘BPI’), an Asian focused clearing business, to further expand its footprint across the Asia Pacific region and provide access to the markets in China.
BPI is a Singapore-based multi-asset clearing business with strong Asia Pacific and China-linked client relationships, adding scale, client balances and regional expertise to Marex. BPI provides its clients with access to commodities and financial products, including FX, index futures and options and digital asset derivatives. The acquisition will add approximately $800m in client balances and over 70 employees across Singapore, Hong-Kong, China, Norway and the United Kingdom.
The deal is subject to regulatory approval and is expected to complete by late 2026 or early 2027.
Thomas Texier, Group Head of Clearing, commented: “BPI is a well-established business with an experienced and high-quality team. This deal will drive additional revenues by adding clients and increasing client balances and is also expected to provide material synergies from the internalization of some clearing activities. Importantly, it will also enhance our ability to service clients in Asia with a broader range of services from the Marex platform and provide existing Marex clients with an improved access to Chinese markets.”
Kenny Mah, Group CEO of BPI said: “Today's announcement marks an exciting new chapter for BPI. Joining Marex represents a significant opportunity to accelerate our growth, broaden the solutions we can offer our clients and provide our people with access to a truly global platform. We share a common commitment to integrity and client service, and I am confident that together we will be even better positioned to support our customers in an increasingly dynamic marketplace.”
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including the expected acquisition of BPI and the closing of the transaction as well as expected benefits from the acquisition. In some cases, these forward-looking statements can be identified by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions.
These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation, the risks discussed under the caption "Managing our Risk" in our Annual Report on Form 20-F for the year ended December 31, 2025, filed with the Securities and Exchange Commission (the "SEC") and our other reports filed with the SEC. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.
About Marex: Marex Group Limited (NASDAQ:MRX) provides market access, infrastructure services and essential liquidity to clients across global commodity and financial markets. The Group provides comprehensive breadth and depth of coverage across four services: Clearing, Agency and Execution, Market Making and Hedging and Investment Solutions. It has a leading franchise in many major metals, energy and agricultural products, with access to more than 60 exchanges. Marex has over 3,400 active clients, including some of the largest commodity producers, consumers and traders, banks, hedge funds and asset managers. With more than 50 offices worldwide, the Group has over 3000 employees across Europe, Asia and the Americas. For more information visit www.marex.com.
HOBOKEN, N.J.--(BUSINESS WIRE)--NiCE (Nasdaq: NICE) today announced the winners of its 2026 International CX Excellence Awards at NiCE World London, recognizing the organizations leading the transformation to AI-first customer experience. This year's honorees have embedded AI across the fabric of their operations. By seamlessly connecting AI agents, human agents, workflows, and data, they have established a new CX operating model that continuously sharpens decisions, accelerates outcomes, and d.
Jihokorejský výrobce paměťových čipů SK Hynix dnes vstupuje na americký trh prostřednictvím depozitních certifikátů (ADR), o které byl mezi institucionálními investory mimořádný zájem.
Pokračování článku je dostupné jen klientům placených služeb Patria Plus / Investor Plus případně uživatelům platformy Patria Direct. Pokud jste klientem těchto služeb, potom je nutné se Přihlásit.
V rámci placeného informačního servisu získáte přístup ke kompletnímu zpravodajství www.patria.cz bez jakýchkoliv omezení. Veškeré zprávy, komentáře a horké zprávy jsou zobrazovány terminálovou metodou (bez nutnosti obnovovat stránku) bez zpoždění a v plné verzi.
Nejen zpravodajství, ale i další služby získáte v Patria Plus / Investor Plus - sms a e-mailové zpravodajství, data z finančních trhů v reálném čase, kompletní analytický servis, rozsáhlé databáze časových řad ke stažení, prognózy vývoje a valuace, ekonomické fundamenty, nástroje a kalkulátory... více
Tagy: akcie, USA, SK Hynix
Reklama
Na tomto místě můžete zahájit diskusi. Zatím nebyl zadán žádný názor. Do diskuse mohou přispívat pouze přihlášení uživatelé (Přihlásit). Pokud nemáte účet, na který byste se mohli přihlásit, registrujte se zde.
Aktuální komentáře
09.07.2026 14:14SK Hynix míří na Nasdaq. O jeden z největších burzovních debutů v historii je obrovský zájem 14:01Nápojový kolos PepsiCo zvýšil čtvrtletní zisk, u růstu tržeb překonal odhady 13:58Výsledková sezóna v USA: Kalendář pro 2. čtvrtletí 2026 13:56Výsledková sezóna v Evropě: Kalendář pro 2. čtvrtletí 2026 13:56Výsledková sezóna Česko: Kalendář pro 2. čtvrtletí 2026 12:04Investiční výhled na druhé pololetí: Shrnutí 11:02Míra nezaměstnanosti v červnu stagnovala 10:51PODCAST Analytický radar: Makrovýhled Patrie pro druhé pololetí 10:23Akcie znovu rostou, zatímco dluhopisy tlumí optimismus 10:19Nezaměstnanost v ČR v červnu stagnovala na 4,8 procenta, přibylo volných míst 9:48Průmyslová výroba v Česku v květnu zrychlila meziroční růst na dvě procenta 8:55Rozbřesk: Potvrdí průmysl zlepšenou kondici ekonomiky? 8:48Kofola zachrání Bílinskou kyselku i Zaječickou hořkou. Uspěla ve výběrovém řízení o tradiční minerálky 8:44Akcie míří vzhůru i přes napětí s Íránem. SK Hynix přitahuje velký zájem a Kofola kupuje tradiční minerálky 6:40Sohn: Google může být ke koupi, kvalita nyní jen zabírá místo v portfoliu 08.07.2026 22:01Akcie oslabily kvůli novému napětí mezi USA a Íránem, ropa prudce zdražila 16:06Apple sází na americké čipy, Broadcom získal kontrakt za více než 30 miliard dolarů 16:04AI a pravidlo „v tom nejlepším přestat“ 14:17L'Oréal, Nestlé či Mondelez. AI zrychluje vývoj šamponů či sušenek 12:19Investiční výhled na druhé pololetí: Strategie
Reklama
Související komentáře
Nejčtenější zprávy dne
Nejčtenější zprávy týdne
Nejdiskutovanější zprávy týdne
Kalendář událostí
ČasUdálost 3:30Čína - CPI, y/y 9:00CZ - Průmyslová výroba, y/y 10:00CZ - Nezaměstnanost 14:30USA - Nové žádosti o dávky v nezam. 16:00USA - Prodeje starších domů, m/m
Pre-Market Stock Futures: Futures are trading mixed after another tough day across Wall Street, with all the major indices crushed early on, before the Nasdaq made a late-afternoon push to wind up just modestly higher at 25,870, up 0.20%. The S&P 500 also rallied in the afternoon, erasing a big deficit, to finish the session down just 0.28% at 7,482. The small-cap Russell 2000, which is still the leading index in 2026, closed at 2,958, down 0.82%, while the Dow Jones Industrial Average took the biggest hit on Wednesday, closing at 52,348, down 1.09%. Needless to say, the re-escalation of the war with Iran once again provides ammunition for more volatility and the potential for another major move lower. Just as oil prices had almost returned to pre-war levels, the fighting resumed, as did the movement higher in the two major benchmarks. The President, like so many before him and around him, is well aware of the stalling tactics of Iran, but this time, the clock may have run out.
Treasury Bonds: Once again, yields were higher across the entire Treasury curve except for the shortest T-bill maturities. The resumption of fighting and rising oil prices bring the rate increase narrative back into the room, especially after the June meeting notes showing that the Fed Governors are very divided on the path forward, and any increases in the inflation readings will likely keep that division in place. Plus, as history shows, if there is a rate increase, it likely won’t be just one, as that has never happened. The 30-year long bond finished the day at 5.07%, while the benchmark 10-year note closed at 4.58%.
Oil and Gas: The minute the war with Iran was back on, so were the prices in the energy complex, as both of the major benchmarks closed the session higher. President Trump has halted any oil sales coming from Iran, while effectively closing the Strait of Hormuz once again. When the final bell rang, Brent Crude closed at $79.12, up a stunning 6.69%, while West Texas Intermediate was last seen at $74.61, up 5.92%. Natural gas closed down 1.26% to $ 3.22. One thing is for sure: Middle East oil producers are expanding pipelines and seeking alternative routes to move their production beyond the Straits.
Gold: For the second day running, Gold traded lower on Wednesday, and the same reasons that drove price lower on Tuesday carried forward, as a stronger dollar and rising interest rates made the non-yielding Gold complex less desirable. Add in the inflation worries associated with higher energy prices, and precious metals end up on the losing side, at least for now. When the final bell rang on Wednesday, Gold closed at $4,074, down 0.73%, while Silver closed at $58.13, down 2.85%.
Crypto: Crypto markets sold off on Wednesday amid heightened U.S.-Iran tensions and the collapse of the ceasefire, sparking a risk-off move. Bitcoin dropped to around $61,800, briefly breaking below the $62,000 level amid broader market weakness and rising oil prices. The decline triggered liquidations and weighed on major altcoins, with sentiment remaining cautious amid ongoing geopolitical uncertainty. At 8 AM EDT, Bitcoin traded at $62,610, while Ethereum traded at $1,741.
24/7 Wall St. reviews dozens of analyst research reports every day to identify fresh investment ideas for investors and traders alike. These daily analyst notes include recommendations on stocks to buy, sell, or avoid, as well as new coverage initiations. Important reminder: No single analyst report should ever be the sole basis for buying or selling a stock.
Here are some of the best Wall Street analyst upgrades, downgrades, and initiations seen on Thursday, July 9, 2026.
Upgrades: American International Group (NYSE: AIG | AIG Price Prediction) was upgraded to Overweight from Neutral at Cantor Fitzgerald, which bumped the target price for the insurance giant to $92 from $85. American Tower (NYSE: AMT) was upgraded to Outperform from Peer Perform at Wolfe Research, which has a $188 target price. Cinemark Holdings (NYSE: CNK) was raised to Neutral from Sell at Goldman Sachs, which bumped the target price for the stock to $30 from $23. Five Below (NASDAQ: FIVE) was upgraded to Outperform from Neutral at Mizuho, which trimmed the price target for the popular retailer to $220 from $225. Toast (NYSE: TOST) was raised to Buy from Neutral at Goldman Sachs, which has set a $36 target price for the shares. Downgrades: Caesars Entertainment (NYSE: CZR) was cut to Equal Weight from Overweight at Barclays, which trimmed the target price for the gaming giant to $31 from $35. Kaiser Aluminum (NASDAQ: KALU) was cut to Underweight from Equal Weight at Wells Fargo, which bumped the target price down to $158 from $160. Salesforce (NYSE: CRM) was downgraded to Sector Weight from Overweight at KeyBanc, without a price target. Mattel (NYSE: MAT) Goldman Sachs downgraded the popular toy and game giant to Sell from Neutral, and dropped the price target to $12 from $15. Tractor Supply (NASDAQ: TSCO) was downgraded to Neutral from Outperform at Mizuho, which cut the target price for the stock to $32 from $50. Initiations: Align Technology (NASDAQ: ALGN) was initiated with an Outperform rating at BMO Capital, with a $209 target price objective. Cohu (NASDAQ: COHU) was started with an Outperform rating at Baird, with a $65 target price. GE Healthcare Technologies (NASDAQ: GEHC) was initiated with a Market Perform rating at BMO Capital with a $70 target price. Intuitive Surgical (NASDAQ: ISRG) was initiated with an Outperform rating at BMO Capital, with a $518 target price. Tesla (NASDAQ: TSLA) was started with a Market Perform rating at Citizens, without a price target. Want Up To $1,000? SoFi Is Giving New Active Invest Users Free StockLooking to grow your money but unsure where to begin? SoFi Active Invest is offering a limited-time promotion—open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts.
From $0 commission trading to fractional shares and automated investing, this app is designed to simplify investing for everyone, whether you’re just starting or already experienced. Its easy to sign up and secure your bonus.
VAUGHAN, Ontario, & MENLO PARK, Calif.--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the creation of Orphia™, a new AI-powered digital health platform built on the belief that eye care providers should spend less time managing disconnected tools and technologies and more time caring for patients. The platform is brand agnostic and designed to serve all eye care providers, r.
Gold (XAU/USD) consolidates modest gains on Thursday, although upside remains limited as renewed hostilities in the Middle East revive concerns over energy-driven inflation and reinforce expectations that the Federal Reserve (Fed) may need to raise interest rates.
At the time of writing, XAU/USD is trading around $4,102, up 0.66% on the day.
The United States (US) and Iran exchanged another round of attacks overnight. US President Donald Trump said on Truth Social, "This is in retribution for yesterday's bombing of ships by Iran. If it happens again, it will get much worse!"
On Wednesday, Iran reiterated its threat to close the Strait of Hormuz if fresh attacks occur, raising concerns that global Oil flows could once again be disrupted after improving following last month's interim peace agreement.
The latest escalation has weakened hopes for a permanent peace agreement, hurting risk sentiment and keeping safe-haven demand intact for the Greenback. The US Dollar Index (DXY), which tracks the Greenback against a basket of six major currencies, trades around 101.00 after touching an intraday low of 100.79.
Meanwhile, hawkish Fed expectations are providing additional support to the USD. According to the CME FedWatch Tool, markets are pricing in a 63% chance of a rate hike at the September meeting. Higher borrowing costs tend to weigh on Gold because the metal does not offer yield.
Analysts at OCBC Bank noted, "While geopolitics would normally offer some support for gold, the latest move has worked more through the oil, inflation and rates channel." They added, "Near term, unless oil stabilises or Fed/rates concerns ease, rallies in gold and silver may still struggle to sustain."
Minutes of the Fed's June 16-17 meeting showed officials remained divided on the interest rate outlook, although some saw a case for higher rates if inflation remains elevated.
Technical analysis: Sellers retain control below the Bollinger middle band
On the daily chart, XAU/USD keeps a bearish near-term bias, with price sitting below the 20-day Simple Bollinger middle band at $4,135. The Relative Strength Index (RSI) at 43.12 remains below the neutral 50 mark, hinting at subdued upside momentum, while the Average Directional Index (ADX) around 37 suggests a reasonably strong prevailing trend despite the latest consolidation.
On the topside, initial resistance emerges at the Bollinger middle band around $4,135, followed by the horizontal barrier at $4,200 and then the Bollinger upper band near $4,326.
On the downside, immediate support is seen at the psychological $4,000 handle, ahead of the lower Bollinger band clustered around $3,944, where buyers could attempt to slow the current corrective phase.
(The technical analysis of this story was written with the help of an AI tool. Know more.)
Gold FAQs Gold has played a key role in human’s history as it has been widely used as a store of value and medium of exchange. Currently, apart from its shine and usage for jewelry, the precious metal is widely seen as a safe-haven asset, meaning that it is considered a good investment during turbulent times. Gold is also widely seen as a hedge against inflation and against depreciating currencies as it doesn’t rely on any specific issuer or government.
Central banks are the biggest Gold holders. In their aim to support their currencies in turbulent times, central banks tend to diversify their reserves and buy Gold to improve the perceived strength of the economy and the currency. High Gold reserves can be a source of trust for a country’s solvency. Central banks added 1,136 tonnes of Gold worth around $70 billion to their reserves in 2022, according to data from the World Gold Council. This is the highest yearly purchase since records began. Central banks from emerging economies such as China, India and Turkey are quickly increasing their Gold reserves.
Gold has an inverse correlation with the US Dollar and US Treasuries, which are both major reserve and safe-haven assets. When the Dollar depreciates, Gold tends to rise, enabling investors and central banks to diversify their assets in turbulent times. Gold is also inversely correlated with risk assets. A rally in the stock market tends to weaken Gold price, while sell-offs in riskier markets tend to favor the precious metal.
The price can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can quickly make Gold price escalate due to its safe-haven status. As a yield-less asset, Gold tends to rise with lower interest rates, while higher cost of money usually weighs down on the yellow metal. Still, most moves depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAU/USD). A strong Dollar tends to keep the price of Gold controlled, whereas a weaker Dollar is likely to push Gold prices up.
South American esports organization 9z punched their ticket to the semifinals of the XSE Pro League Guangzhou 2026 on July 9, taking down China’s TYLOO in a 2-1 best-of-three quarterfinal series. The match was part of a Valve Tier 1 tournament carrying a total prize pool of $1 million, making it one of the more significant competitive Counter-Strike events of the year.
How the match played out 9z, ranked roughly 11th-12th globally, entered the series as slight favorites against a TYLOO squad sitting around 22nd in world rankings. The South Americans justified that positioning with a convincing 13-9 victory on Nuke to open the series.
Advertisement
TYLOO fought back on Mirage, forcing a tie that went to extra rounds. But 9z closed things out on Inferno to secure the 2-1 series win and a spot in the final four.
The tournament itself is organized by Xinsai Esports, known as XSE, a Chinese firm. The event runs from July 1 through July 12, with playoff matches taking place at notable Guangzhou venues including Friendship Hall and South China Agricultural University Gymnasium.
That $1 million prize pool is split evenly between player share and club share. Half goes directly to the players and the other half goes to the organizations they compete under.
The crypto-shaped hole in esports After the 2021-2022 boom when every esports org from TSM to Fnatic was inking deals with FTX, Coinbase, and a parade of now-defunct exchanges, the industry has largely retreated to traditional sponsorship models. The collapse of FTX alone left several organizations scrambling to replace naming rights deals worth tens of millions.
XSE’s ability to put up $1 million for a single tournament without a crypto sponsor attached reflects where the money is actually coming from in competitive gaming right now: corporate sponsors, media rights, and event organizers with deep pockets.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
Přinášíme vám kalendář vybraných firemní výsledků pro domácí výsledkovou sezónu za druhé čtvrtletí roku 2026. Na Patria.cz pro Vás výsledkovou sezónu průběžně pokrýváme.
Zdrojem uvedených dat jsou kalendáře význačných událostí pro investory zveřejněné samotnými emitenty. Přesné datum a čas se mohou měnit a nejsou průběžně aktualizovány. Tituly uvedené v tomto kalendáři jsou aktuálně komponenty hlavního indexu PX Burzy cenných papírů Praha.
Legenda: Typ - E - Expected (očekávané datum); C - Confirmed (potvrzené datum); Odhad EPS je odhad analytiků oslovených agenturou Bloomberg
Tagy: výsledky, akcie, ČR, výsledková sezóna
Reklama
EPS u seznamu českých akcií se zobrazuje pouze uživatelům tarifu Patria Platinum. :))
Berounskej
Aktuální komentáře
09.07.2026 14:01Nápojový kolos PepsiCo zvýšil čtvrtletní zisk, u růstu tržeb překonal odhady 13:58Výsledková sezóna v USA: Kalendář pro 2. čtvrtletí 2026 13:56Výsledková sezóna v Evropě: Kalendář pro 2. čtvrtletí 2026 13:56Výsledková sezóna Česko: Kalendář pro 2. čtvrtletí 2026 12:04Investiční výhled na druhé pololetí: Shrnutí 11:02Míra nezaměstnanosti v červnu stagnovala 10:51PODCAST Analytický radar: Makrovýhled Patrie pro druhé pololetí 10:23Akcie znovu rostou, zatímco dluhopisy tlumí optimismus 10:19Nezaměstnanost v ČR v červnu stagnovala na 4,8 procenta, přibylo volných míst 9:48Průmyslová výroba v Česku v květnu zrychlila meziroční růst na dvě procenta 8:55Rozbřesk: Potvrdí průmysl zlepšenou kondici ekonomiky? 8:48Kofola zachrání Bílinskou kyselku i Zaječickou hořkou. Uspěla ve výběrovém řízení o tradiční minerálky 8:44Akcie míří vzhůru i přes napětí s Íránem. SK Hynix přitahuje velký zájem a Kofola kupuje tradiční minerálky 6:40Sohn: Google může být ke koupi, kvalita nyní jen zabírá místo v portfoliu 08.07.2026 22:01Akcie oslabily kvůli novému napětí mezi USA a Íránem, ropa prudce zdražila 16:06Apple sází na americké čipy, Broadcom získal kontrakt za více než 30 miliard dolarů 16:04AI a pravidlo „v tom nejlepším přestat“ 14:17L'Oréal, Nestlé či Mondelez. AI zrychluje vývoj šamponů či sušenek 12:19Investiční výhled na druhé pololetí: Strategie 10:45Rotace pryč z nastoupaných techů, konec příměří s Íránem a další růst výnosů
Reklama
Související komentáře
Nejčtenější zprávy dne
Nejčtenější zprávy týdne
Nejdiskutovanější zprávy týdne
Kalendář událostí
ČasUdálost 3:30Čína - CPI, y/y 9:00CZ - Průmyslová výroba, y/y 10:00CZ - Nezaměstnanost 14:30USA - Nové žádosti o dávky v nezam. 16:00USA - Prodeje starších domů, m/m
Potřebujte poradit?
Přinášíme Vám kalendář výsledkové sezóny v západní Evropě za druhé čtvrtletí. Seznam obsahuje vybrané společnosti obchodované na západoevropských burzách. Na Patria.cz Vás budeme výsledkovou sezónou provádět a přinášet zprávy, komentáře a analýzy k jednotlivým titulům.
Uvedená data jsou platná ke dni vydání tohoto kalendáře a jejich zdrojem je agentura Bloomberg. Přesná data a čas se mohou měnit.
Legenda: Typ - E - Expected (očekávané datum); C - Confirmed (potvrzené datum); T - Tentative (předběžné datum); Bef-mkt - před otevřením trhu; Aft-mkt - po otevření trhu.
Tagy: investice, výsledky, akcie, kalendář, Evropa, výsledková sezóna
Reklama
Sloupce neodpovídají popisu v hlavičce :-(
oh171
Tak ještě jednou, sloupec Čas a Typ jsou prohozeny, stejně jako sloupec Odhad EPS a Období. Opravdu je tak těžké to opravit?
oh171.
Aktuální komentáře
09.07.2026 14:01Nápojový kolos PepsiCo zvýšil čtvrtletní zisk, u růstu tržeb překonal odhady 13:58Výsledková sezóna v USA: Kalendář pro 2. čtvrtletí 2026 13:56Výsledková sezóna v Evropě: Kalendář pro 2. čtvrtletí 2026 13:56Výsledková sezóna Česko: Kalendář pro 2. čtvrtletí 2026 12:04Investiční výhled na druhé pololetí: Shrnutí 11:02Míra nezaměstnanosti v červnu stagnovala 10:51PODCAST Analytický radar: Makrovýhled Patrie pro druhé pololetí 10:23Akcie znovu rostou, zatímco dluhopisy tlumí optimismus 10:19Nezaměstnanost v ČR v červnu stagnovala na 4,8 procenta, přibylo volných míst 9:48Průmyslová výroba v Česku v květnu zrychlila meziroční růst na dvě procenta 8:55Rozbřesk: Potvrdí průmysl zlepšenou kondici ekonomiky? 8:48Kofola zachrání Bílinskou kyselku i Zaječickou hořkou. Uspěla ve výběrovém řízení o tradiční minerálky 8:44Akcie míří vzhůru i přes napětí s Íránem. SK Hynix přitahuje velký zájem a Kofola kupuje tradiční minerálky 6:40Sohn: Google může být ke koupi, kvalita nyní jen zabírá místo v portfoliu 08.07.2026 22:01Akcie oslabily kvůli novému napětí mezi USA a Íránem, ropa prudce zdražila 16:06Apple sází na americké čipy, Broadcom získal kontrakt za více než 30 miliard dolarů 16:04AI a pravidlo „v tom nejlepším přestat“ 14:17L'Oréal, Nestlé či Mondelez. AI zrychluje vývoj šamponů či sušenek 12:19Investiční výhled na druhé pololetí: Strategie 10:45Rotace pryč z nastoupaných techů, konec příměří s Íránem a další růst výnosů
Reklama
Související komentáře
Nejčtenější zprávy dne
Nejčtenější zprávy týdne
Nejdiskutovanější zprávy týdne
Kalendář událostí
ČasUdálost 3:30Čína - CPI, y/y 9:00CZ - Průmyslová výroba, y/y 10:00CZ - Nezaměstnanost 14:30USA - Nové žádosti o dávky v nezam. 16:00USA - Prodeje starších domů, m/m
Patria.cz Vám přináší kalendář výsledkové sezóny firem obchodovaných v Severní Americe za druhý kvartál. Uvidíme, které společnosti překonají očekávání a které naopak zaostanou za odhady. Uvedená data jsou platná k datu aktualizace článku a jejich zdrojem včetně odhadů zisku na akcii (EPS) je agentura Bloomberg.
Legenda: Typ - E - Expected (očekávané datum); C - Confirmed (potvrzené datum); T - Tentative (předběžné datum); Bef-mkt - před otevřením trhu; Aft-mkt - po otevření trhu.
Tagy: výsledky, akcie, USA, výsledková sezóna
Reklama
Ani tady sloupce neodpovídají popisu v hlavičce :-( Poslední 2 jsou prohozeny.
oh171
Konkrétně tedy sloupce Odhad EPS a Období jsou prohozeny a stále neopraveny :-(
oh171.
a přece jim tady všichni, znalci ekonomických závislostí, předpovídají brzký zanik. Tady něco neštimuje. A navíc nejzadluženější stát světa. Škoda že tu dnes není náš Vševěd profesor, aby nám to vysvětlil. Kde je toho soudruha konec. Snad mu nepraskla cévka. Já mu furt říkal ZiXilouši neber si to tak, vymstí se ti to. Ale co, ten má asi ted' už jiné starosti, už asi válčí v Syriji. 33
1482
Aktuální komentáře
09.07.2026 14:01Nápojový kolos PepsiCo zvýšil čtvrtletní zisk, u růstu tržeb překonal odhady 13:58Výsledková sezóna v USA: Kalendář pro 2. čtvrtletí 2026 13:56Výsledková sezóna v Evropě: Kalendář pro 2. čtvrtletí 2026 13:56Výsledková sezóna Česko: Kalendář pro 2. čtvrtletí 2026 12:04Investiční výhled na druhé pololetí: Shrnutí 11:02Míra nezaměstnanosti v červnu stagnovala 10:51PODCAST Analytický radar: Makrovýhled Patrie pro druhé pololetí 10:23Akcie znovu rostou, zatímco dluhopisy tlumí optimismus 10:19Nezaměstnanost v ČR v červnu stagnovala na 4,8 procenta, přibylo volných míst 9:48Průmyslová výroba v Česku v květnu zrychlila meziroční růst na dvě procenta 8:55Rozbřesk: Potvrdí průmysl zlepšenou kondici ekonomiky? 8:48Kofola zachrání Bílinskou kyselku i Zaječickou hořkou. Uspěla ve výběrovém řízení o tradiční minerálky 8:44Akcie míří vzhůru i přes napětí s Íránem. SK Hynix přitahuje velký zájem a Kofola kupuje tradiční minerálky 6:40Sohn: Google může být ke koupi, kvalita nyní jen zabírá místo v portfoliu 08.07.2026 22:01Akcie oslabily kvůli novému napětí mezi USA a Íránem, ropa prudce zdražila 16:06Apple sází na americké čipy, Broadcom získal kontrakt za více než 30 miliard dolarů 16:04AI a pravidlo „v tom nejlepším přestat“ 14:17L'Oréal, Nestlé či Mondelez. AI zrychluje vývoj šamponů či sušenek 12:19Investiční výhled na druhé pololetí: Strategie 10:45Rotace pryč z nastoupaných techů, konec příměří s Íránem a další růst výnosů
Reklama
Související komentáře
Nejčtenější zprávy dne
Nejčtenější zprávy týdne
Nejdiskutovanější zprávy týdne
Kalendář událostí
ČasUdálost 3:30Čína - CPI, y/y 9:00CZ - Průmyslová výroba, y/y 10:00CZ - Nezaměstnanost 14:30USA - Nové žádosti o dávky v nezam. 16:00USA - Prodeje starších domů, m/m
Americká společnost PepsiCo ve druhém čtvrtletí zvýšila provozní zisk meziročně o 125 procent na 4,02 miliardy dolarů (85,3 miliardy Kč), čisté tržby se zvýšily o 6,4 procenta na 24,18 miliardy USD. Výrobce nápojů a pochutin o tom dnes informoval ve své výsledkové zprávě. Růst tržeb navzdory slabší poptávce v Severní Americe překonal očekávání. Firma se chce dál více soustředit na nabídku zdravějších produktů.
Analytici podle společnosti LSEG očekávali, že firma zvýší čisté tržby o 5,4 procenta na 23,95 miliardy USD. Firma uvedla, že za slabší poptávkou v Severní Americe jsou zejména obavy spotřebitelů z vývoje ekonomiky, které lidi nutí omezovat výdaje. Dosavadní celoroční výhled ale firma ponechala beze změn.
V únoru, před finále amerického fotbalu Super Bowl, firma ve Spojených státech snížila ceny svých brambůrků Lay’s, chipsů Doritos, Cheetos a Tostitos až o 15 procent. Reagovala tak na rostoucí nespokojenost spotřebitelů po několika letech zdražování. Tento krok v prvním čtvrtletí podpořil poptávku po slaných pochutinách v Severní Americe.
Ve druhém čtvrtletí však objem prodeje pochutin v Severní Americe stagnoval, zatímco objem prodeje nápojů o čtyři procenta klesl. Firma uvedla, že důvodem byl mimo jiné růst cen pohonných hmot v důsledku války v Íránu. Silnější prodej firma zaznamenala na zahraničních trzích. Celkový objem prodeje pochutin se zvýšil o tři procenta a objem prodeje nápojů vzrostl o dvě procenta.
Společnost uvedla, že bude nadále investovat do toho, aby její výrobky byly cenově dostupnější. PepsiCo se zároveň snaží reagovat na poptávku spotřebitelů po zdravějších produktech. V březnu firma uvedla na trh nápoj Gatorade Lower Sugar, který neobsahuje umělá aromata ani barviva.
Čistý zisk se ve druhém čtvrtletí více než zdvojnásobil na 2,98 miliardy dolarů. Po očištění o jednorázové položky firma vydělala 2,18 dolaru na akcii, což ale zaostalo za odhadem analytiků, kteří očekávali zisk 2,19 dolaru na akcii.
Akcie PepsiCo v předobchodní fázi před zahájením dnešního obchodování v New Yorku posilovaly téměř o jedno procento. Později ale zisky smazaly a začaly oslabovat.
The Chinese Yuan has remained resilient against the US Dollar despite a stronger Greenback, with USD/CNY holding close to 6.80 as investors weigh China's domestic policy support against robust US economic data.
Goldman Sachs believes the Yuan's resilience reflects structural changes within China's economy rather than short-term market dynamics.
The bank notes that while a stronger Dollar has created headwinds for many Asian currencies, the Yuan has held up comparatively well thanks to Beijing's continued focus on financial self-reliance and currency internationalisation.
According to Goldman Sachs, "resilient CNY" reflects the increasing importance of domestic drivers, even as global markets continue to favour the US Dollar.
The bank argues that China's push to expand cross-border use of the Renminbi, together with steady capital account reforms and continued policy support, should help underpin the currency over the medium term.
At the same time, Goldman Sachs acknowledges that weaker domestic growth has kept Chinese interest rates low, limiting the Yuan's yield advantage relative to the Dollar.
While US monetary policy is likely to remain the dominant short-term driver of USD/CNY, Goldman Sachs expects China's structural reforms and continued internationalisation of the Renminbi to help keep the Yuan relatively resilient despite broader Dollar strength.
The Euro to Dollar (EUR/USD) exchange rate has steadied near 1.1425 after recovering from June's lows, although Rabobank believes the single currency has lost much of the momentum that drove its rally earlier this year.
The bank expects EUR/USD to trade broadly sideways over the next one to three months before regaining a modest upward bias later in the year.
Rabobank argues that optimism surrounding Germany's decision to loosen its debt brake has faded as investors refocus on weaker Eurozone growth, higher energy costs and lingering competitiveness challenges.
According to the bank, last year's fiscal shift in Germany "was no panacea", with structural reforms still needed to tackle sluggish productivity and weak long-term growth.
Rabobank also notes that markets are already fully priced for another European Central Bank rate increase this year, limiting the Euro's ability to gain further support from monetary policy.
While the US Dollar continues to benefit from a resilient economy, the bank believes expectations for additional Federal Reserve tightening have become excessive and should gradually unwind.
Even so, Rabobank expects investors to remain reluctant to rebuild large long Euro positions in the coming months after the currency's strong performance over the past year.
The bank believes investors will remain cautious in the near term. According to Rabobank, "the market is likely to be reluctant to rebuild large, long positions in the EUR in the months ahead."
However, it also argues that expectations for further Federal Reserve tightening have become excessive. As the bank puts it, "we expect sideways trading in EUR/USD on a 3-month view and a modest upward bias to emerge in the currency pair on a 3-to-6-month view."
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- Shutterstock, Inc. (NYSE: SSTK), a family of brands delivering scalable creative and GenAI solutions to help customers fuel great work, will report its second quarter 2026 business and financial results on Thursday, August 6, before the market opens.
The company will host a conference call at 8:30 a.m. ET to discuss the results. The conference call is being webcast live and can be accessed by either visiting the Company's website at https://investor.shutterstock.com or clicking here for direct access. The webcast is listen-only.
A replay of the webcast will be available on the Company's website on the same day at approximately 10:30 a.m. ET.
ABOUT SHUTTERSTOCK
Shutterstock is in the business of turning ideas into impact. Powered by a global network of millions of creators and our cutting-edge technology, we provide businesses, creatives, and brand leaders with the essential, universal ingredients to make their work more effective. Shutterstock offers access to one of the world's largest and most diverse collections of high-quality licensable assets, specialized training datasets, evaluation tools, and end-to-end strategic partnerships for the full model training lifecycle, as well as advertising and distribution solutions, exclusive editorial content, and full-service studio production—delivering unparalleled resources to fuel great work.
Discover our impact at www.shutterstock.com and connect with us on LinkedIn, Instagram, X, Facebook and YouTube.
Shares in Navitas Semiconductor (NVTS 4.50%) rose by an incredible 151% in the first half of 2026, according to the data from S&P Global Market Intelligence. The performance comes down to a transformative bet that its management took in recent years, and the good news is it's working.
Navitas pivots toward high-growth markets The company's roots lie in lower-margin power chips for mobile and consumer electronics applications. However, its future lies in gallium nitride (GaN) and silicon carbide (SiC) power chips and devices for high-power, higher-margin end markets. These markets include AI data centers, energy infrastructure, high-performance computing, and electrification.
Today's Change
(
-4.50
%) $
-0.63
Current Price
$
13.36
While these end markets appear to be a list of buzzwords that define the investment themes that have worked this year, Navitas isn't a latecomer to these markets, nor did it fall into them by accident. In contrast, management has deliberately focused on transitioning the business toward these end markets.
Navitas pivots to high-growth end markets However, as exciting as the pivot is, it hasn't come without challenges, and the chart below shows what you might call a "valley of death" as its traditional revenue declined, pushing the company from profit to loss.
NVTS Revenue (TTM) data by YCharts
Where next for Navitas Semiconductor The company undoubtedly has exciting long-term growth prospects, not least due to its partnership with Nvidia and its potential to grow sales through power conversion solutions for a new generation of data centers that Nvidia is developing an architecture for. The new 800-volt high-voltage direct current (HVDC) centers have a radically different structure that leverages the advantages of Navitas solutions.
In addition, Navitas has a major growth opportunity in grid infrastructure. As CEO Chris Allexandre noted at a Morgan Stanley conference earlier in the year, "without a change of the grid infrastructure, you cannot enable the size and the magnitude of the AI data center rollout that we're going to see in the future."
Image source: Getty Images.
That said, Navitas isn't currently profitable, and according to Wall Street analysts, it won't be until at least 2029. As such, the stock is often treated as a proxy for how the market is feeling about the momentum behind the AI investment boom on any given day, week, or month.
Still, the stock's massive outperformance in 2026 is a clear indication that expectations for spending on AI data centers, grid modernization, and electrification have increased significantly throughout the year. That's a major plus for Navitas, but you will have to be patient before it shows up in its numbers.
Wolfspeed stock is charging ahead with explosive momentum. What’s behind WOLF gains? The lawsuit asserts that a broad range of Navitas products infringes multiple Wolfspeed patents, including five specifically named U.S. patents covering GaN and SiC semiconductor technology. Products accused of infringement span major Navitas product lines — including its GaNFast, GaNSlim, and GaNSafe GaN-based FET families, as well as Navitas’s GeneSiC MOSFETs and SiCPAK modules.
“Wolfspeed’s foundational technology helped create this industry, and we are deeply committed to defending the intellectual property that represents decades of innovation and R&D investment,” said Robert Feurle, CEO. “Protecting our patent portfolio is a strategic priority for the company and our shareholders.”
Wolfspeed Stock Still Faces Technical HeadwindsAt $37.09, Wolfspeed is still trading 20% below its 20-day SMA ($45.55) and 27% below its 50-day SMA ($49.90), which keeps the intermediate trend tilted lower despite the premarket strength. The stock is also trading 4.4% above its 100-day SMA ($34.90) and 31.9% above its 200-day SMA ($27.63), so the longer-term uptrend structure hasn’t fully broken.
The 20-day SMA sitting below the 50-day SMA is a bearish crossover that often acts like "gravity" on rallies until price can reclaim those averages. At the same time, the 50-day SMA remains above the 200-day SMA (a golden cross that occurred in October 2025), which is typically a longer-term bullish backdrop—but it can lose usefulness if price stays pinned below the 50-day for too long.
MACD is the cleaner momentum lens right now: it’s below its signal line and the histogram is negative, which points to upside pressure cooling versus the prior upswing unless buyers can rebuild momentum. Put simply, when MACD is below its signal line, rallies are more likely to fade until momentum flips back in buyers’ favor.
Key Resistance: $36.50 — a nearby pivot area that can cap rebounds, especially with price still well below the 20-day and 50-day moving averages overhead. Wolfspeed Shares Edge HigherWOLF Price Action: At the time of publication, Wolfspeed shares are trading 3.18% higher at $37.00, according to data from Benzinga Pro.
Image via Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
